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1 Abstract 
 
Since the discovery of the protein modifier ubiquitin, the knowledge and understanding of its role in 
cellular processes has increased tremendously. In the area of DNA damage response (DDR), 
ubiquitylation has been shown to have important roles in facilitating checkpoint signaling and DNA 
repair upon exposure to genotoxic stress. Many ubiquitylated proteins, ubiquitin ligases and 
deubiquitylating enzymes with roles in the DDR pathways have been discovered.  
 
The genomes of all living species, including mammalian cells, are under constant attack by DNA 
damaging agents from both endogenous and exogenous sources. To restore genomic integrity, 
damaged DNA needs to be repaired, which require accumulation of repair proteins to the sites of 
damage. We and others have discovered a role of the ubiquitin ligase RNF8 in DDR, which has 
increased our knowledge on the mechanism of accumulation of repair proteins to site of DNA 
damage. We show that RNF8 rapidly assembles at chromatin flanking DNA double-strand breaks 
(DSBs) via interaction with the mediator protein Mdc1. The assembly of RNF8, which is dependent 
on phosphorylated Mdc1, is accompanied by an increase in ubiquitin conjugates and accumulation of 
53BP1 and BRCA1 at the DSB-flanking chromatin. Disruption of the binding of RNF8 to Mdc1 or 
its ubiquitin ligase activity impaired the DSB-associated ubiquitylations and inhibited the 
accumulation of 53BP1 and BRCA1 at the DSB sites. We found the target of RNF8 to be histones 
H2A and H2AX, and their RNF8 mediated ubiquitylation is suggested to recruit 53BP1 and BRCA1 
to the DSB sites, to facilitate repair of the DNA.        
 
Upon DNA damage, DNA repair is coordinated with cell cycle progression through checkpoint 
mechanisms, which allow cells to arrest the cell cycle until the damage has been repaired. Claspin is 
an important mediator protein, which facilitates the ATR-mediated phosphorylation and activation of 
the key checkpoint kinase Chk1. We identified the deubiquitylating enzyme USP7 as a novel 
regulator of Claspin stability, and USP7 is required to maintain steady-state levels of Claspin. At 
G2/M, Claspin is degraded by the SCF
βTrCP
 ubiquitin ligase, and over-expression of USP7 was found 
to counteract this degradation and stabilize Claspin in mitosis. Over-expression of USP7 also 
increased the half-life of Claspin, which in turn increased the magnitude and duration of Chk1 
phosphorylation in response to genotoxic stress, and USP7 was found to deubiquitylate Claspin both 
in vivo and in vitro. We furthermore identified Claspin as a substrate of APC
Cdh1
-mediated 
degradation in G1, and USP7 was found to only counteract the SCF
βTrCP
- and not the APC
Cdh1
-
mediated degradation of Claspin.  
 
This thesis has contributed to the discovery of novel roles of ubiquitylation and deubiquitylation in 
the DDR pathways. Identification of RNF8 has contributed significantly to the understanding of the 
accumulation of 53BP1 and BRCA1 to the site of damage and the role of ubiquitylation in these 
processes. Furthermore, the discovery of the role of USP7 in regulating the steady-state level of 
Claspin has increased the knowledge on the flexible mechanisms to keep a tight regulation of Chk1. 
There are still many questions to be answered about their exact mechanism and regulation, and it is 
very likely that ubiquitylation has more roles in the DDR pathways, and more substrates and 
regulators will be discovered in the future.    
 
 
 
  2
2 Dansk Resumé 
 
Siden ubiquitins rolle som postranslationel protein modification blev opdaget, er kendskabet og 
forståelse for dens rolle i cellulære processer vokset kolossalt. Ubiquitylering har vist sig at spille en 
vigtig rolle i det cellulære respons til DNA-skade, specielt i forbindelse med checkpoint signalering 
og DNA-reparation efter genotoksisk stress. I de seneste år er mange ubiquitylerede proteiner, 
ubiquitin ligaser og deubiquitylerings enzymer, med betydning for det cellulære respons til DNA 
skade, blevet beskrevet. 
 
Genomer i alle levende arter, herunder celler fra pattedyr, er under konstant angreb fra DNA 
skadelige stoffer af endogen og eksogen art. For at genoprette genomisk integritet skal beskadiget 
DNA repareres, hvilket kræver en akkumulering af reparationsproteiner omkring DNA skaden. Vi og 
andre har beskrevet ubiquitin ligasen RNF8’s rolle i DNA skade respons, hvilket har øget vores 
forståelse for de mekanismer, der fører til akkumulering af reparations-proteiner omkring skadet 
DNA. Vi viser, at RNF8 hurtigt interagerer med chromatin området omkring DNA dobbelt-strengs 
brud (DSB) via interaktion med adaptor proteinet Mdc1. Akkumulering af RNF8, som er afhængig af 
fosforyleret Mdc1, er fulgt af en stigning i ubiquitin konjugater og en akkumulering af 53BP1 og 
BRCA1 omkring det dobbelt-strengede brud. Forstyrrelse af bindingen af RNF8 til Mdc1 eller dets 
ubiquitin ligase aktivitet nedsatte DSB-associeret ubiquitylering og hæmmede akkumulering af 
53BP1 og BRCA1 til DSB. Den direkte funktion af RNF8 formodes at være via ubiquitylering af 
H2A og H2AX, hvilket rekruterer 53BP1 og BRCA1 til DNA skaden og muliggører reparation af 
brudet. 
 
Efter DNA-skade er DNA-reparation koordineret med cellecyklus progression gennem checkpoint 
mekanismer, der gør det muligt for cellerne at stoppe cellecyklus indtil skaden er blevet repareret. 
Claspin er et vigtigt protein involveret i ATR-medieret fosforylering og aktivering af den centrale 
checkpoint kinase Chk1. Vi identificerede det deubiquitylerende enzym USP7 som en ny regulator af 
Claspin stabilitet, og USP7 er nødvendig for at opretholde steady-state niveau af Claspin. I G2/M 
nedbrydes Claspin efter ubiquitylering af ubiquitin ligasen, SCF
βTrCP
, og over-udtryk af USP7 
modvirker denne nedbrydning og stabiliserer Claspin i mitose. Over-udtryk af USP7 øger også 
halveringstiden af Claspin, som igen øger mængden og varigheden af Chk1 phosphorylering efter 
genotoksisk stress, og USP7 deubiquitylerer Claspin både in vivo og in vitro. Vi har desuden 
identificeret Claspin som et mål af APC
Cdh1
-medieret nedbrydning i G1. USP7 modvirker kun den 
SCF
βTrCP
- og ikke den APC
Cdh1
-medierede nedbrydning af Claspin. 
 
Denne afhandling har bidraget til opdagelsen af nye roller for ubiquitylering og deubiquitylering 
inden for det cellulære respons til DNA skade. Identifikation af RNF8 har bidraget væsentligt til 
forståelsen af akkumulering af 53BP1 og BRCA1 omkring steder med DNA skade, og betydningen 
af ubiquitylering i disse processer. Hertil kommer, at opdagelsen af USP7’s rolle i regulering af 
steady-state niveauet af Claspin har øget vores viden om de fleksible mekanismer, der anvendes til at 
fastholde en tæt regulering af Chk1. Der er stadig mange spørgsmål, der skal besvares om den 
nøjagtige mekanisme og dens regulering, og det er meget sandsynligt, at ubiquitylering har flere 
roller i det cellulære respons til DNA skade, og at flere substrater og proteiner involveret i dets 
regulering, vil blive opdaget i fremtiden. 
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3 Introduction 
 
The maintenance of genome integrity is essential for the proper function and survival of all living 
species. In order to deal with genotoxic insults, mammalian cells have developed elegant 
mechanisms that detect and repair lesions in the genome. The DNA damage response (DDR) is a 
multifaceted response that senses DNA damage or replication stress and coordinates the repair with 
cell cycle progression. The response acts through sensors, transducers and effectors to coordinate cell 
cycle arrest with DNA repair, cellular senescence and apoptosis, if the damage is too severe. This 
ensures a low occurrence of mutations, and aberrations in the DDR may therefore lead to 
developmental defects or genetic diseases including neurodegenerative syndromes, premature aging 
and cancer (Kastan and Bartek, 2004;Nyberg et al., 2002). 
 
In the last decade, advances have been made in the discovery and understanding of the many proteins 
and signaling pathways in the DDR. From only knowing the involvement of ATM, p53, p21 in the 
apoptosis and cell cycle arrest pathways 10 years ago, many more factors and regulating mechanisms 
have been discovered. One of most important advances is the increased understanding of the 
involvement of protein phosphorylation and ubiquitylation in executing the cellular responses to 
DNA damage (Harper and Elledge, 2007). 
 
Ubiquitin was originally isolated in 1975 by Gideon Goldstein and coworkers as the protein 
ubiquitous immunopoietic polypeptide (UBIP) in a search for hormones of the thymus (Goldstein et 
al., 1975). Ubiquitin has later been found to be involved in many cellular processes. One of the first 
links between DDR and ubiquitin was in 1990, where it was shown that the E6 protein from human 
papillomavirus (HPV) and its associated protein E6-AP were able to bind p53 and promote 
degradation of p53 via the ubiquitin pathway (Huibregtse et al., 1991;Scheffner et al., 1990). In 1996 
it was discovered, that the budding yeast protein Rad6 was an E2 conjugating enzyme and Rad23 
contained an ubiquitin binding domain which was required for its function. Both proteins were 
identified many years earlier in a screen of radiosensitive mutants (Game and Mortimer, 1974). In 
2000, Mailand and coworkers discovered ubiquitin- and proteasome- dependent degradation of 
Cdc25A upon DNA damage (Mailand et al., 2000) and it was not until 2002 that ubiquitylation of 
PCNA, the link to Rad6, and its involvement in DNA repair was discovered (Hoege et al., 2002).  
 
Today, we know that ubiquitylation has many more substrates and functions in DDR, and ubiquitin 
has been found to be involved in both protein turnovers, in mediating protein interactions and in 
regulating protein functions. Indeed, many ubiquitylated proteins, ubiquitin ligases, deubiquitylating 
enzymes and ubiquitin binding proteins have a role in DDR. And there is still much to learn; there 
are many uncharacterized proteins with role in ubiquitylation and especially very few of the 
deubiquitylating enzymes are characterized. Furthermore, when it comes to a specific understanding 
of the ubiquitin function and regulation, there are still many unanswered questions and mechanisms 
waiting to be discovered.  
 
The goal of this PhD thesis is to contribute to this knowledge. With the discoveries presented, I hope 
to shed more light on several mechanism of ubiquitylation and deubiquitylation in the DDR and 
checkpoint pathways.  
 
The thesis is divided into two main parts which are the “Introduction” and the “Results and 
Discussion”. In the introduction, the first area described is ubiquitylation which is the main focus of 
the thesis. In this part, the nature of ubiquitin, mechanism of ubiquitylation, proteasomal degradation, 
and the established knowledge on ubiquitin ligase and deubiquitylating enzymes (DUBs) are 
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described. Furthermore, examples of ubiquitylated proteins, ubiquitin ligases and deubiquitylating 
enzymes involved in DDR are presented. The second area covers the cell cycle and describes what 
drives the cell cycle and how it is regulated by phosphorylation and ubiquitylation. Focus is put on 
the different ubiquitin ligases involved in cell cycle regulation. The last area described deals with the 
cellular responses to DNA damage. This part covers DNA damage, repair pathways and focus is put 
on the DNA damage response pathways initiated from double strand breaks, with an emphasis on 
initiation, termination and recovery from the G2/M checkpoint.  
 
In the results and discussion part, the two main projects, I have been involved in, will be presented. 
In the first project, the novel involvements of the RNF8 ubiquitin ligase in histone ubiquitylation and 
in facilitating recruitment of 53BP1 and BRCA1 to sites of damage are presented. In the second 
project, the novel role of the deubiquitylating enzyme USP7 in maintaining steady-state levels of 
Claspin is presented.   
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3.1 The Ubiquitin system 
 
Ubiquitylation is a post-translational modification of proteins. Due to the nature of ubiquitin, which 
is a highly conserved small globular protein of 76 amino acids and 8.5 kDa (Wilkinson and Audhya, 
1981), this protein modifier shows greater versatility, than many other types of protein modifications. 
An extensive amount of proteins are found to be modified by ubiquitin or involved in adding or 
removing the modifier from proteins. Furthermore, many proteins are found to contain special 
domains that mediate their binding to ubiquitylated proteins. 
 
Ubiquitin is present in all eukaryotic cells (from yeast to humans) and is present in all cell 
compartments, where it is involved in both selective degradations of many short-lived (also some 
long-lived) proteins, and in changing the properties and localization of many proteins. The ubiquitin 
system is involved in many cellular processes including intracellular trafficking, signal transduction, 
cell cycle progression, transcriptional regulation, receptor down-regulation, endocytosis, immune 
response, apoptosis and DNA repair (Haglund and Dikic, 2005;Hershko and Ciechanover, 
1998;Tanaka and Chiba, 1998).  
Ubiquitylation 
Ubiquitin becomes covalently attached to the lysine residues (N-terminal amino group is also known 
to be ubiquitylated) of substrate proteins by the action of three classes of enzymes. The first is an 
ubiquitin activating enzyme (E1). In this step, the C-terminal glycine residue (Gly76) of ubiquitin is 
activated in an ATP requiring step, and ubiquitin is bound to a cysteine residue of the E1 enzyme. In 
the second step, the activated ubiquitin is transferred to a cysteine residue of an ubiquitin conjugating 
enzyme (E2). Third, an ubiquitin ligating enzyme (E3, ubiquitin ligase) links the C-terminus of 
ubiquitin to the ε-amino group of a lysine residue in the substrate protein, through formation of an 
isopeptide bond (Hershko et al., 1983;Wilkinson, 1995). An overview of the ubiquitylation reaction 
is given in Figure 1 and a representation of ubiquitin is given in Figure 2A.  
 
 
 
Figure 1: An overview of protein ubiquitylation. Ubiquitylation involves conjugation of one or more ubiquitin moieties onto a 
substrate protein by the action of an ubiquitin activating enzyme (E1), an ubiquitin conjugating enzyme (E2) and an ubiquitin ligating 
enzyme (E3). Ubiquitylated proteins can be degraded in the proteasome or have non-degradative functions. Deubiquitylating enzymes 
(DUBs) prepare free ubiquitin from precursors or remove ubiquitin from ubiquitin chains or directly from substrates (Sun, 2008).   
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The covalent attachment of ubiquitin to substrate proteins can result in monoubiquitylation, where a 
single ubiquitin is conjugated to the protein. If the protein is multiubiquitylated, several ubiquitin 
moieties are linked to the same protein, but each at a different site. Furthermore, proteins can become 
polyubiquitylated, where several ubiquitin moieties are linked through isopeptide bonds between the 
c-terminal glycine in one ubiquitin to a lysine in another ubiquitin, forming an ubiquitin polymer. 
See Figure 2C. Ubiquitin contains seven different lysines which are: K6, K11, K27, K29, K33, K48 
and K63 and the five most common lysines applied in chain formation are presented in Figure 2B. It 
is believed that all lysines can be used for polyubiquitylation in vivo as all were identified in a 
proteomic analysis of ubiquitin conjugated proteins in yeast (Peng et al., 2003). In addition, the 
formation of forked polyubiquitin chains have been observed in yeast (Peng et al., 2003) and 
heterogeneous polyubiquitin chains have been observed in vitro (Kim et al., 2007b).  
 
      A. B. C. 
              
     
 
 
Monoubiquitylation 
 
Multiubiquitylation 
 
 
Polyubiquitylation 
 
 
Figure 2: The topology of ubiquitin and examples of ubiquitylation products. (A) Ribbon and surface representation of ubiquitin 
with the C-terminal Gly76 marked (Hurley et al., 2006). (B) Surface representation of ubiquitin with the five most applied lysines 
depicted in blue (Hurley et al., 2006). (C) Different types of ubiquitylation products which are monoubiquitylation, multiubiquitylation 
and polyubiquitylation (Hoeller et al., 2006). 
 
The best characterized lysines of ubiquitin applied for polyubiquitin chains are K48 and K63. In 
general are K48 linked polyubiquitylated proteins targets of proteasomal degradation, whereas K63 
linked polyubiquitylation and monoubiquitylation have more regulatory roles in cellular function. 
Examples of regulatory roles are to mediate interactions between ubiquitylated proteins and ubiquitin 
binding proteins, change of protein function and activity and change of cellular localization.  
 
Examples of ubiquitylated proteins involved in D"A damage response 
Examples of monoubiquitylated proteins include PCNA, FANCD2, histone H2A, and the TLS 
polymerases polη and polι. Examples of polyubiquitylated proteins include PCNA, Cdc25A, Claspin, 
Ku80, DDB2, XPC and RNA polymerase II (Busino et al., 2003;Huang and D'Andrea, 2006;Jason et 
al., 2002;Mailand et al., 2006;Postow et al., 2008). 
Proteasomal degradation 
Polyubiquitylated proteins destined for proteolysis are degraded by the 26S proteasome which is 
present in the cytosol and nucleus of eukaryotic cells (Palmer et al., 1994;Reits et al., 1997;Tanaka 
and Chiba, 1998). Proteasomal degradation seems to be the major system for selective protein 
degradation in eukaryotic cells (Hersko and Ciechanover, 1992). The 26S proteasome is a large 
multisubunit protease complex of approximately 2 MDa and consist of a 20S catalytic core onto 
which two 19S regulatory subunits are attached (Koster et al., 1995). Ubiquitylated proteins are 
recognized and bound by the 19S subunits which deubiquitylate, unfold and translocate the proteins 
into the 20S catalytic core in an ATP-dependent manner, where it is cleaved into short polypeptides 
(Zwickl et al., 2000). Upon degradation of proteins in the 26S proteasome, free and reusable 
ubiquitins are released (Ciechanover, 1994). Proteasomal degradation of regulatory proteins is 
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important in regulating many processes including cell cycle progression, signal transduction, 
transcription regulation, receptor down-regulation and endocytosis (Hershko and Ciechanover, 
1998).  
Ubiquitin ligases 
Only a few E1 enzymes are known in mammalian cells which are estimated to have more than 20 
different E2s and between 500 and 1000 different E3s. Yeast in contrast has only 1 E1, 11 E2 and 54 
E3 (Hicke et al., 2005;Hoeller et al., 2006). The main function of E1s and E2s is to prepare ubiquitin 
for conjugation and E3s are primarily responsible for the specific recognition of target proteins. 
Ubiquitin ligases exist as single polypeptides or associated with other proteins in multisubunit 
complexes and are categorized into four major classes based on their specific structural motif. These 
are the HECT-type, RING-type, U-box-type and PHD-type. Deregulation of several RING-type and 
HECT-type E3s contributes to cellular tumorigenesis and due to their tumor suppressors or 
oncogenic properties, they are considered as important potential targets in cancer therapy 
(Bernassola et al., 2008;Sun, 2003). 
 
      A. B. 
        
   
     
Figure 3: HECT-type and RI"G-type ubiquitin ligases. (A) HECT-type ubiquitin ligases load the ubiquitin onto itself after 
binding the E2 before transfering the ubiquitin to the target. (B) RING-type ubiquitin ligases bind E2 which transfer the ubiquitin 
directly to the target protein (Sullivan et al., 2003). 
 
Homologous to E6-AP carboxyl terminus (HECT)-type E3s differ from the three other ubiquitin 
ligase families by possessing built-in catalytic activity and by executing the ubiquitylation reaction 
differently from the others. The family contains a large C-terminal HECT domain of approximately 
350 amino acids with an E2 binding site and an active cysteine, separated by a short flexible linker 
(Kee and Huibregtse, 2007). To ubiquitylate substrates, the HECT-type E3 binds an E2 and load the 
ubiquitin onto its own catalytic cysteine to form a thiolester with ubiquitin before transferring it onto 
the substrate (Bernassola et al., 2008). See Figure 3A.The first characterized HECT-type E3 ligase is 
the E6-associated protein (E6-AP). Other HECT-type E3s are Huwe1, Nedd4, Itch and Smurfs.  
 
The really interesting new gene (RING)-type E3s lack the catalytic site of HECT-type ligases and 
function primarily as scaffolds orienting the E2-ubiquitin complex and the target protein for 
ubiquitin transfer (Wang and Pickart, 2005). The RING-finger domain, which contains eight cysteine 
and histidine residues to coordinate two zinc molecules, mediates the interaction with the E2, and it 
is the E2 that transfer ubiquitin directly to the target protein. See Figure 3B. It has become clear that 
many, but probably not all, RING-finger-containing proteins function as ubiquitin ligases. RING-
type E3s include both monomeric proteins like Mdm2 and multimeric protein complexes like SCF 
and APC. 
 
U-box-type E3s are predicted to be very similar in three-dimensional structure as RING-type E3s 
despite the lack of a zinc binding domain. Instead, the E3s contain a U-box domain which consists of 
approximately 70 amino acids. Most, if not all, U-box proteins interact with molecular chaperones or 
co-chaperones which suggest a role mainly in quality control of accumulated abnormal proteins 
(Hatakeyama and Nakayama, 2003).  
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PHD-type E3s is a novel class of E3 ubiquitin ligases which contain a plant homeo-domain, a 
specialized form of zinc finger that is related to the RING-finger domain. It is not known how many 
of PHD-finger containing proteins are E3 ligases. These E3 ligases control the trafficking and/or 
degradation of target proteins involved in different cellular functions outside the nucleus. Examples 
of PHD-type E3s are MIR and MK3, which are membrane-bound (Coscoy and Ganem, 2003).  
 
The RING-finger and PHD-finger share similarities in structure and size with classical zinc-fingers 
which apply four cysteine and histidine residues to coordinate a single zinc atom. Originally, zinc-
fingers were only considered as DNA binding motifs, but are now known to also recognize RNA and 
proteins (Gamsjaeger et al., 2007).  
 
Examples of ubiquitin ligases involved in DDR 
Examples of ubiquitin ligases involved in DDR are Mdm2, BRCA1/BARD1, FANCL, Rad18 and 
RNF8. SCF and APC are multi-subunit ubiquitin ligases involved in the regulation of cell cycle 
progression and cell cycle checkpoints and are described later. All of these ubiquitin ligases are 
RING-type E3s except FANCL which is a PHD-type E3 (Meetei et al., 2003). Mdm2 has a C-
terminal RING-finger with activity against p53 and itself, and is one of several ubiquitin ligases 
involved in regulating p53 activity ((Honda and Yasuda, 2000;Fang et al., 2000). BRCA1 contains a 
RING-finger and forms a heterodimer with another RING-type E3, BARD1. The BRCA1/BARD1 
complex is found to be able to autoubiquitylate through K6 chain formation (Wu-Baer et al., 2003). 
BRCA1/BARD1 is involved in DNA repair, and a newly identified substrate is the chromatin bound 
protein CtIP (Yu et al., 2006) which is required for resection of DNA ends during homologous 
recombination (Sartori et al., 2007). RNF8 was recently discovered to be involved in DDR by 
facilitating local ubiquitylation of histones involved in recruitment of repair proteins to site of 
damage (Huen et al., 2007;Kolas et al., 2007;Mailand et al., 2007). This ubiquitin ligase is also 
described later. FANCL is involved in monoubiquitylation of FANCD2 during normal replication 
and in response to DNA damage (Meetei et al., 2004;Taniguchi et al., 2002). Upon treatment with 
DNA damaging agents, PCNA becomes ubiquitylated by E2 Rad6 and E3 Rad18 (Hoege et al., 
2002;Kannouche et al., 2004). 
Deubiquitylating enzymes 
Deubiquitylating enzymes (DUBs) reverse the action of ubiquitin ligases by hydrolyzing the 
isopeptide bond between ubiquitin and the substrate protein or between two ubiquitin moieties. The 
enzymes are involved in keeping the proteasome free of ubiquitin, in the recycling ubiquitin and in 
proofreading ubiquitin-protein conjugates. Furthermore, they are involved in processing inactive 
ubiquitin precursors which are synthesized with a C-terminal extension or linear precursor fusion 
proteins (Amerik and Hochstrasser, 2004;D'Andrea and Pellman, 1998;Wilkinson, 1997). DUBs are 
believed to be functionally as important as ubiquitin ligases, but much less are known about them. 
The enzymes are less characterized in terms of function, specificity and regulation of their activity. 
Furthermore, only few substrates have been assigned. But it is known, that the DUBs are involved in 
many cellular functions and in diseases such as cancer and neurodegeneration (Nijman et al., 2005b).      
 
DUBs belong to the protease superfamily, which has an estimated 553 members (Puente et al., 
2003). The majority of DUBs are cysteine proteases and a few are metallo proteases. The DUBs that 
are cysteine proteases can be further divided into four groups based on their ubiquitin protease 
domain which are Ubiquitin specific protease (USP), ubiquitin C-terminal hydrolase (UCH), Ovarian 
Tumor-related protease (OTU) and Machado-Joseph disease protease (MJD). All DUBs that are 
metalloproteases have an ubiquitin protease domain called JAMM (Jab1/MPN/Mov34 
metalloenzyme). In a search for genes whose transcript encodes one of these five ubiquitin protease 
domains, 95 putative DUBs were found. 79 of these are believed to be expressed and functional 
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(Amerik and Hochstrasser, 2004;Nijman et al., 2005b). The catalytic activity of cysteine proteases by 
definition depends on the thiol group of a cysteine in the catalytic domain which is deprotonated by 
an adjacent histidine. Together with aspartate, the three residues make up a catalytic triad. In 
catalysis, the cysteine makes a nucleophilic attack on the carbonyl of the isopeptide bond between 
the target protein and ubiquitin. This results in a release of the target protein and formation of a 
covalent bond between the DUB and ubiquitin. Upon contact with a water molecule, the ubiquitin is 
released from the DUB (Nijman et al., 2005b).  
 
The USP group of DUBs is the largest, most diverse and best studied. The catalytic domain of this 
group of DUBs contain two short and well conserved motifs named the Cys and His boxes which are 
critical for catalysis. The two boxes are separated by 300-800 unrelated amino acids which may 
serve a regulatory function. Many interesting protein domains including ubiquitin binding, ubiquitin-
like or zinc-fingers have been identified in the N-terminal and/or C-terminal part of the catalytic 
domain and are likely involved in the substrate specificity of the DUBs. USP DUBs appear to be 
specific for proteins modified with ubiquitin (Amerik and Hochstrasser, 2004;Nijman et al., 2005b). 
 
The UCH group of DUBs is more conserved in amino acid sequence than the USP DUB group and 
has four members. The UCH DUBs were the first described but their specific functions are still 
poorly understood. They are believed to be involved in the recycling of ubiquitin when ubiquitin is 
inappropriately conjugated to intracellular nucleophiles like glutathione or polyamines. Furthermore, 
they are believed to be involved in the processing of ubiquitin from polyubiquitin precursors or when 
fused to ribosomal protein precursors (Amerik and Hochstrasser, 2004;Nijman et al., 2005b). 
 
The OTU group of DUBs was discovered in a bioinformatic study (Makarova et al., 2000). The 
catalytic triad in a recently solved OTU structure was incomplete and is stabilized by another method 
using a hydrogen bonding network instead (Nanao et al., 2004;Balakirev et al., 2003).         
 
The MJD group of DUBs includes Ataxin-3 and a number of Ataxin-3-like proteins. The enzymes 
have low sequence similarity with other DUBs but NMR structures show conservation in the overall 
arrangement of the catalytic triad. Ataxin-3 has shown deubiquitylating activity which has not yet 
been demonstrated for the other MJD DUBs, and their biological functions remains unknown 
(Amerik and Hochstrasser, 2004;Nijman et al., 2005b) . 
 
Metallo proteases have no active cysteine residue but instead two histidines and an aspartate. 
Together with a Zn
2+
 bound polarized water molecule, the residues generate a non-covalent 
intermediate with the substrate. The ubiquitin is also released from DUB upon contact with a water 
molecule (Ambroggio et al., 2004;Nijman et al., 2005b). The JAMM group of DUBs includes 
Rpn11/POH1 which is a subunit of the 19S proteasomal lid with activity against ubiquitylated 
proteins (Verma et al., 2002). Another DUB in this group is AMSH which associates with a protein 
involved in regulating receptor sorting in the endosome (McCullough et al., 2004).  
 
Examples of deubiquitylating enzymes in DDR 
Examples of DUBs involved in DDR are USP1, USP3, USP7 and USP28. USP1 is believed to be the 
DUB of ubiquitylated FANCD2 and PCNA (Huang and D'Andrea, 2006;Nijman et al., 2005a). USP3 
has been suggested to deubiquitylate histone H2A and H2B and is required for S-phase progression 
and genome stability (Nicassio et al., 2007). USP7 is suggested to be the DUB of both p53 and its 
ubiquitin ligase, Mdm2, and is involved in regulating p53 stability (Li et al., 2002;Li et al., 
2004;Cummins and Vogelstein, 2004). USP28 was found to be a DUB of Claspin and counteracts its 
APC
Cdh1
 mediated degradation in response to DNA damage in G2 (Bassermann et al., 2008).  
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Ubiquitin-binding domains 
Ubiquitin-binding domains (UBDs) are a group of protein domains that non-covalently bind to 
ubiquitin. The domains are small with 20-150 amino acids and are structurally diverse with different 
biological functions. Ubiquitin-binding proteins apply UBDs to directly interact with monoubiquitin 
or polyubiquitin chains. The domains can be found in enzymes involved in ubiquitylation and 
deubiquitylation. Furthermore, they can be found in proteins that recognize and interpret signals 
from ubiquitylated substrates. The presence of a UBD in a protein indicates that it can interact with 
ubiquitin or ubiquitylated proteins and it might be regulated by ubiquitylation itself (Hicke et al., 
2005). In 2006, 16 different UBDs had been identified and the domains bind various surfaces on 
ubiquitin (Hurley et al., 2006). A newly identified protein with UBDs involved in DDR is Rap80 
which is involved in targeting BRCA1 to site of DNA damage. The protein has two UIM domains 
which bind polyubiquitin chains (Wang et al., 2007;Sobhian et al., 2007;Kim et al., 2007a).  
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3.2 The Cell Cycle 
 
The cell cycle is the process where a cell duplicates its entire DNA and divides into two new 
genetically identical daughter cells. The cell cycle of mammalian cells consists of four phases which 
are synthesis (S), mitosis (M) and two gap phases (G1 and G2). See Figure 4A. In S-phase, which is 
the longest phase of the cell cycle, the entire DNA is replicated to produce two identical copies. 
After DNA replication, the DNA is segregated and divided into two new cells in the mitosis phase. 
An overview of the different phases of mitosis is given in Figure 4B. The S and M phases are 
separated with two gap phases G1 and G2, which gives the cell time to grow and monitor internal 
and external signals and to ensure proper timing for entering S or M phase. The interphase of the cell 
cycle covers G1, S and G2, and a round of cell division generally takes about 24 hours in rapidly 
cycling cells in culture.  
 
   A.  B. 
            
 
Figure 4: An overview of the cell cycle. (A) The different phases of the cell cycle include the S phase where the cell replicates its 
entire genome, mitosis where the cell divide into two identical daughter cells and the two gap phases G1 and G2. R represents the 
restriction point from where the cell commit to a round of replication and division. (B) Detailed overview of the different phases of 
mitosis where the cell carefully divides the replicated DNA into two new daughter cells. Modified from (Barr et al., 2004). 
 
The cell cycle is a tightly regulated process and in multicellular organisms, most eukaryotic cells 
only divide during development and when dead cells need renewal in developed organism. In a 
developed organism, most cells are kept in a non-replicative stage (quiescent stage, G0) and only 
divides when the cellular and tissue environment are favorable and only in the presence of mitogenic 
factors, which signals the need for cell proliferation. Cells harbor several mechanisms to sense the 
presence of mitogenic factors as well as anti-proliferative signals or damage that prevents cell cycle 
progression. Extracellular signals are sensed through transmembrane cell surface receptors which are 
coupled to intracellular signaling circuits. At the onset of the cell cycle in G1, mitogenic factors 
stimulate the expression of proto-oncogenes such as Ras and Myc, which results in transcriptional 
regulation leading to increased proliferation (Berthet and Kaldis, 2007;Bartek and Lukas, 2001).  
 
A special feature of cell cycle is the unidirectionality. As soon as the cells has committed to 
duplication, the cell goes through the entire cycle and through the different cell phases without 
returning to a previous one. This is ensured by the degradation of proteins that are needed in previous 
stages. Many proteins undergo proteolysis at different cell cycle transitions and slowly synthesized 
proteins are rapidly degraded which provides an irreversible mechanism that blocks the way back, 
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thus driving the cell cycle forward. The gradual accumulation and abrupt degradation of cyclins 
cause oscillations in cdk activities which are the major regulator of the cell cycle progression 
(Vodermaier, 2004). Cell cycle checkpoints are networks of signaling pathways that monitor the 
order and quality of the cell cycle. With checkpoints, cells actively halt progression through the cell 
cycle until it can ensure that an earlier process such as DNA replication or mitosis is complete. 
Besides the DNA damage checkpoints that recognize and respond to DNA damage at the G1/S, intra 
S and G2/M, the cells sense the fidelity of DNA replication (replication checkpoints) and make sure 
all chromosomes are aligned before entering mitosis (spindle checkpoint in metaphase). The cell 
cycle checkpoints are generally not essential for cell cycle progression but are best viewed as 
accessory braking systems to avoid accumulation of mutations or large scale changes in chromosome 
composition, which can promote cancer (Hartwell and Weinert, 1989;Nyberg et al., 2002).   
Cyclins and cdks 
Cyclin-dependent kinases (cdks) are a family of serine/threonine kinases which are dependent on 
association with cyclins to become active. Cyclins were discovered as proteins that accumulate 
progressively through interphase and disappear abruptly at mitosis during each cell cycle (Hunt, 
2004;Evans, 2004). They were later found to function in mitosis as well as other phases of the cell 
cycle. Different cyclins are present in different phases of the cell cycle and are regulated by protein 
synthesis and degradation. The level of cdks remains constant but the activity oscillates throughout 
the cell cycle due to changes in the presence of cyclins. Phosphorylation of specific targets by cyclin-
cdk complexes is crucial for progression through the cell cycle in a timely manner. Cdks regulate 
important processes like DNA replication, mitosis, centrosome/spindle pole duplication or 
chromosome condensation either directly or through various effector kinases (Morgan, 1997;Fung 
and Poon, 2005).  
 
In S. cerevisiae, only one cdk, Cdc28, associate with several cyclins to regulate the cell cycle. 
Mammalian cells posses multiple cdks which are each dependent on a particular cyclin. The first 
family of cyclins to be induced is the D-type to activate Cdk4/Cdk6. The complexes phosphorylate 
and activate the retinoblastoma protein (Rb) which promotes progression through the restriction 
point (R), which is at late G1 and serves as mark for the decision to commit to replication of the 
genome and division. From here, cells switch from mitogen-dependent growth to largely growth 
factor independent progression into S and beyond. Phosphorylation of Rb activates E2F dependent 
transcription of genes including Cyclin E and other factors required for DNA replication. Cyclin E 
activates Cdk2 to initiate S-phase which is maintained by Cyclin A-Cdk2. Mitosis is driven by the 
activity of Cyclin B-Cdk1 and to a lesser extent Cyclin A-Cdk1 (Bartek and Lukas, 2001;Berthet and 
Kaldis, 2007;Morgan, 1997). An overview of the different cyclin-cdk complexes activated during the 
different stages of the cell cycle is given in Figure 5.   
 
Figure 5: Activation of cyclin-cdk complexes during the cell cycle. Cyclin D1-Cdk4/6 activity mediates passage through the 
restriction point (R). Cyclin E-Cdk2 initiates S-phase which is maintained by Cyclin A-Cdk2. Cyclin B-Cdk1 and Cyclin A-Cdk1 
drives the mitosis.    
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Cdk inhibitors (CKIs) are negative regulators of cyclin-cdk complexes and can be divided into two 
families depending on their structure and target which are the INK4 proteins and the CIP/KIP 
proteins. INK4 proteins specifically bind Cdk4 and Cdk6 to inhibit their catalytic activity. CIP/KIP 
proteins include p21, p27, and p57 and inhibit the activities of Cyclin D-, E- and A-cdk complexes 
by binding both cyclin and cdk subunits (Morgan, 1997;Sherr and Roberts, 1999;Wade Harper and 
Elledge, 1996). 
 
Ubiquitin dependent proteolysis as a key determinant of cell cycle transitions 
The amount of cyclins, CKIs and many other cell cycle regulators oscillate during the cell cycle as a 
result of accumulation and degradation. The degradation of these proteins is mediated by the 
ubiquitin-proteasome system. Two major ubiquitin ligases are responsible for the periodic 
proteolysis of many regulators of the cell cycle. These are the Anaphase Promoting Complex (APC) 
and the Skp1-Cul1-F-box protein (SCF) complex. The SCF and APC complexes are structurally 
similar, each consisting of invariable core subunits and a variable substrate recognition subunit. The 
different subunits are presented in Figure 6 A and B. Despite structurally similar, the APC and SCF 
have different cellular functions. 
 
      A. 
 
B. 
 
Figure 6: The APC and SCF ubiquitin ligase 
complexes together with an E2 (Ubc). (A) The 
APC complex consist of the RING-finger 
protein Apc11, the scaffold protein Apc2, many 
other subunits which are shown in red and the 
variable adaptor protein which are Cdc20 or 
Cdh1. (B) The SCF complex consist of the 
RING-finger protein Roc1/Rbx1, the scaffold 
protein Cul1/Cdc53, the adaptor protein Skp1 
and a variable F-box protein (Reed, 2003). 
                  
SCF complex 
The SCF complex consist of Rbx1 (RING-finger protein), Cul1 (scaffold protein) and Skp1 (adapter 
protein) and a variable F-box protein which bind to Cul1. Approximately 70 F-box proteins have 
been identified in humans and at least three are involved in cell cycle control. These are Skp2, Fbw7 
and βTrCP, which gives substrate specificity to SCF. The SCF was originally thought to function 
mainly at the G1-S transition but is active from late G1 to early M. The activity of SCF is constant 
and SCF only ubiquitylates specific phosphorylated target proteins in most cases. These include 
G1/S cyclins and certain CKIs controlling S-phase initiation (Nakayama and Nakayama, 
2005;Nakayama and Nakayama, 2006). As illustrated in Figure 7, the three F-box proteins are 
involved in both cell cycle promotion and cell cycle inhibition. 
 
 
 
Figure 7: Functions of Skp2, Fbw7 and βTrCP. The three different SCF F-box proteins Skp2, Fbw7 and βTrCP and their major 
targets are shown. Red boxes indicate cell cycle promoters and blue boxes cell cycle inhibitors. Skp2 promotes cell cycle through 
targeting CKIs. Fbw7 inhibits the cell cycle through targeting cell cycle promoters. βTrCP both promotes and inhibits the cell cycle. 
F: F-box protein, LRR: Leucine-rich repeats, Ub: Ubiquitin, WDs: WD40 repeats (Nakayama and Nakayama, 2006). 
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Skp2 
The F-box protein Skp2 is involved in executing entry into S-phase by targeting the cdk inhibitors 
p21 and p27 for degradation (Carrano et al., 1999;Bornstein et al., 2003). Many other proteins are 
reported as targets including p57 which is a tumor suppressor involved in keeping cdks inactive in 
G0 and is degraded upon transition into G1 (Kamura et al., 2003). APC
Cdh1
 preserves the inhibition 
of Cdk1 and Cdk2 in G1 by targeting Skp2 for degradation. When cells commit to enter the cell 
cycle, accumulated Emi1 inhibit APC
Cdh1
 during S and G2, which then releases Skp2 to execute its 
functions (Cardozo and Pagano, 2004).  
 
Fbw7 
The F-box protein Fbw7 has shown to be a tumor suppressor by targeting several growth promoters 
including Cyclin E, Myc, Jun, Notch1 and Notch4 for degradation. Cyclin E is involved in the G1/S 
transition and is targeted for degradation in a phosphorylation dependent manner as is the case for 
the other Fbw7 substrates (Nakayama and Nakayama, 2005;Welcker and Clurman, 2008). 
  
βTrCP 
βTrCP proteins are highly evolutionally conserved and involved in many signaling pathways. The 
consensus sequence recognized by βTrCP is the DSGX2+nS destruction motif where the serines are 
phosphorylated by specific kinases (Hattori et al., 1999). βTrCP targets β-catenin and IκBα for 
ubiquitylation and degradation. β-catenin is an important mediator of Wnt signaling and IkBα is an 
inhibitor of the transcription factor NFκB. Other substrates include IκBβ, IκBε, transcription factor 
Atf4, p105, p100, subunits of NFκB and the disc large tumor suppressor.  
 
βTrCP also exerts direct control of cell cycle regulators including the two negative regulators Emi1 
and Wee1 and the positive regulator Cdc25. Emi1 accumulates in S phase and G2 where it blocks the 
degradation of Cyclin A and Cyclin B by inhibiting the activity of both APC
Cdc20
 and APC
Cdh1
 
(Reimann et al., 2001a;Reimann et al., 2001b). Degradation of Emi1 is therefore necessary for 
activation of APC in late mitosis. In early mitosis, Emi1 is phosphorylated by Plk1 on a DSGXXS 
motif and is subsequently recognized by SCF
βTrCP
 which leads to its degradation and contributes to 
activation of APC (Moshe et al., 2004). The tyrosine kinase Wee1 phosphorylates and inhibits the 
activity of Cyclin B-Cdk1 in S and G2, hereby functioning as a negative regulator of cell cycle 
progression. To allow rapid activation of Cdk1, Wee1 needs to be down-regulated at the onset of 
mitosis. Wee1 is phosphorylated by Plk1 at two phosphorylation sites without having a canonical 
βTrCP destruction motif. Wee1 are then recognized by SCF
βTrCP
 and degraded (Watanabe et al., 
2004). βTrCP also regulates the abundance of the phosphatase Cdc25A. E2F and c-myc transcription 
factors stimulate transcription of Cdc25A in mid to late G1. Through activation of Cdk1 and Cdk2 
by dephosphorylation, Cdc25A induce S-phase entry, progression through S and mitosis. Cdc25A is 
phosphorylated by Chk1 upon DNA damage in S phase and G2 followed by phosphorylation of its 
DSGXXXXS destruction motif by an unknown kinase, allowing recognition and ubiquitylation by 
βTrCP. Both the constitutive and DNA damage induced turnover of Cdc25A depends on SCF
βTrCP
.  
(Busino et al., 2003;Jin et al., 2003).  
 
More recently, the adaptor protein Claspin was also identified as a substrate of βTrCP. Claspin is 
required for stabilization and ATR-mediated activation of Chk1. At the onset of mitosis or during 
recovery from genotoxic stress, Claspin becomes phosphorylated on its N-terminal βTrCP 
recognition motif, DSGXXS, by Plk1 leading to its ubiquitylation by SCF
βTrCP
, and degradation by 
the proteasome (Mailand et al., 2006;Peschiaroli et al., 2006;Mamely et al., 2006). The function and 
regulation of Claspin will be described in more details later.   
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APC complex 
Cdk activity drives cell cycle progression as far as metaphase, but to enter anaphase and beyond, the 
activity of APC is needed (Sullivan and Morgan, 2007). The APC consist of Apc11 (Rbx1-related 
RING-finger protein), Apc2 (Cul1-related scaffold protein) and at least 11 other components without 
defined role together with a variable activator. Two different activators functioning in the cell cycle 
are Cdc20 and Cdh1. Additional APC activators are found to function in non-diving cells and during 
meiosis (Nakayama and Nakayama, 2006). The activity of APC changes through the cell cycle and 
its activity are turned on mainly by binding of the activating subunits to the complex. APC is active 
from early mitosis until end of the G1 phase. Interaction of APC with Cdc20 requires cdk 
phosphorylation on multiple sites of APC while interaction with Cdh1 is irrespective of APC 
phosphorylation. Instead cdk phosphorylation of Cdh1 is required for association with APC 
(Vodermaier, 2004). APC recognises specific motifs in the primary sequence of target proteins 
which includes mitotic cyclins and other regulators of mitosis. The best studied APC degradation 
motifs are the destruction box (D box) with the consensus sequence RXXLXXXXN, which is 
recognized by both APC
Cdc20
 and APC
Cdh1
, and the KEN box with the consensus sequence 
KENXXXN, which is also recognized by APC
Cdh1 
(Wäsch et al., 2005). 
 
Cdc20 
Cdc20 is expressed in G2 before entering M phase but the activity of APC
Cdc20
 is suppressed until all 
chromosomes are attached correctly to mitotic spindles and aligned, also known as the spindle 
checkpoint. Thus Cdc20 becomes active from early mitosis and is active until the M to G1 transition, 
where it is targeted for degradation by APC
Cdh1
. The major targets of Cdc20 are securin and mitotic 
cyclins. Degradation of securin results in initiation of chromosome segregation by unleashing the 
protease Separase which destroys sister-chromatid cohesions. Degradation of mitotic cyclins (Cyclin 
A and B) results in inactivation of cdks, allowing phosphatases to dephosphorylate many cdk 
substrates, which are required for the events of anaphase and telophase. These events include 
chromosome and spindle movements, spindle disassembly, reformation of nuclei and decondensation 
of chromatin (Sullivan and Morgan, 2007).  
 
Cdh1 
The activity of Cdh1 during cell cycle is regulated by phosphorylation and dephosphorylation. Cdh1 
is phosphorylated by cdks during S, G2 and early M, preventing access of Cdh1 to the core APC 
subunits. In late M and G1 phases, Cdh1 is activated due to a drop in cdk activity and 
dephosphorylation by Cdc14 which allows Cdh1 to interact with APC core subunits and target 
proteins for degradation. Cdh1 has a broader specificity than Cdc20 and the many protein targets 
include mitotic cyclins (Cyclin A and B), mitotic kinases like Plk1 and Aurora kinases, proteins 
involved in spindle function like kinesins and proteins involved in DNA replication like Cdc6 and 
geminin. Cdh1 hereby acts mainly to ensure ordered mitotic exit, cytokinesis and to prevent 
premature S phase activation.  
 
Interplay between SCF and APC 
There is indication of a tight interplay between the SCF and APC and that the two complexes control 
each other. SCF
βTrCP
 mediates the degradation of Emi1 in prometaphase which is an inhibitor of APC 
and contributes to its activation (mentioned above). During G1, APC
cdh1
 promotes proteolysis of 
Skp2 and its cofactor Cks1 thus preventing premature degradation of SCF
βTrCP
 substrates. 
Furthermore there is a high level of cross talk between the two complexes. An example is Cdc25A 
which contains both a KEN box and a phosphodegron, and is degraded by the APC
Cdh1
 at the end of 
mitosis, and by SCF
βTrCP
 in S and G2, as mentioned above (Busino et al., 2003).  
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Cell cycle as a three layered process 
An overview of the different layers of the cell cycle are presented in Figure 8. Overall, the cell cycle 
is driven by and regulated by the execution of phosphorylation and ubiquitylation reactions. The 
events of the cell cycle including replication and mitosis which are qualitatively controlled by 
phosphorylation which are largely dependent on cdks, cyclins (accelerators) and CKIs (brakes). 
These accelerators and brakes are quantitatively regulated by ubiquitylation involving ubiquitylating 
enzymes (Nakayama and Nakayama, 2006).  
 
 
 
Figure 8: Cell cycle viewed as a three layered process. The cell cycle can be viewed as a three layered process in which the cell 
cycle progression (A) with DNA synthesis and mitosis is regulated qualitatively by phosphorylation. The phosphorylation activities 
is executed by the cdks (B) influenced by CKIs which are furthermore regulated quantitatively by ubiquitylating enzymes (C) 
(Nakayama and Nakayama, 2006) 
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3.3 Cellular responses to DNA damage 
 
Preserving the integrity of the genome is demanding due to the continuous threat of adverse genetic 
changes from a plethora of DNA lesions. DNA lesions can be caused by genotoxic insults from the 
environment but also from the cells own metabolism. If DNA lesions are not repaired, they can result 
in gene mutations which eventually can lead to development of cancer. Indeed, the cellular responses 
to DNA damage constitute one of the most important fields in cancer biology (Bartek et al., 2004).  
 
Cells have evolved to deal with the different sources of DNA damaging agents through the 
development of elegant mechanisms that detect and repair damage to the genome. The DNA damage 
response (DDR) orchestrates the appropriate repair and resolution of replication problems and 
coordinates these processes with the ongoing cellular physiology (Harper and Elledge, 2007). Upon 
identification of damaged or abnormally structured DNA, eukaryotic cells directly halt the cell cycle 
progression, repair the DNA or undergo programmed cell death if the damage is too excessive. This 
coordination is critical for cell survival, especially when DNA replication is perturbed (Matsuoka et 
al., 2007). The cellular response to DNA damage depends on the type of damage and which cell 
cycle phase the cells are in, and can be considered more as flexible networks than strict linear 
pathways.  
Types and sources of D"A damage 
DNA damaging agents directly damage bases or break the phosphodiester backbone on which the 
bases reside. Types of DNA damage are mainly base loss, base modifications, single strand breaks 
(SSB), double strand breaks (DSB), inter and intra strand crosslinks. At the cellular level, DNA 
damages can hamper transcription of genes, replication of DNA and result in cell cycle arrest, 
chronic mutations and cell death. At the organism level, DNA damages have been implicated in 
carcinogenesis, genetic disorders and in ageing (Altieri et al., 2008). DNA lesions can be caused by 
environmental insults such as ionizing or ultra violet radiation, various genotoxic compounds and 
drugs. They can also be caused by endogenous genotoxic insults from reactive cellular metabolites 
naturally occurring in the cell. The chemical events that lead to DNA damage include attack by 
water, reactive oxygen species and other reactive metabolites (Hoeijmakers, 2001;De Bont and van 
Larebeke, 2004;Lindahl and Wood, 1999).  
 
The bonds between bases and sugar residues in the backbone are relatively labile and attack by water 
causes hydrolysis of the glycosylic bond and results in formation of mutagenic abasic sites (De Bont 
and van Larebeke, 2004). Reactive oxygen species are one of the major sources of DNA damage and 
are formed continuously in living cells. ROS comes from mitochondria, peroxisomes, cytochrome 
P450 enzymes, antimicrobial oxidative burst of phagocytic cells and other biological reactions. The 
species include superoxide, hydrogen peroxide, hydroxyl radical and singlet oxygen which attacks 
the bases or deoxyribose moieties for oxidation and result in adducts, cross links, single and double 
strand breaks. The most abundant damage from ROS is formation of the oxidized base 8-oxo-Gua (8-
oxo-7,8-dihydroguanine) which results in mispairing of guanine to adenine. Deleterious ROS are 
also produced upon exposure of cells to various chemical and physical agents such as certain drugs, 
UV light and IR. Exposure to reactive nitrogen species like peroxynitrate results in deamination of 
DNA bases and other base modifications are formed by reaction with alkylating and methylating 
agents. Furthermore, platinum compounds like cisplatin is able to covalently bind to DNA bases, 
producing intra and inter strand cross links (Altieri et al., 2008;De Bont and van Larebeke, 
2004;Lindahl and Wood, 1999).    
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Exogenous sources of DNA damage include ultraviolet (UV) and ionizing radiation (IR). Ionizing 
radiation of cells can produce highly reactive radical species and cause a broad spectrum of lesions 
similar to those produced by ROS and include damage to purine and pyrimidine rings, AP sites and 
strand breaks. Radiation by the UV component of sunlight primarily generates the helix-distorting 
lesions cyclobutane pyrimidine dimers (CPDs) and (6-4) photoproducts (6-4PPs) from direct 
excitation of nucleobases. CPDs result in mainly T pairing with T and 6-4PPs result mainly in T 
pairing with C (Altieri et al., 2008;Lindahl and Wood, 1999).  
 
To protect the genome, cells need to detect all types of DNA damage and structural alterations 
including nicks, gaps, strand breaks and the many alterations that block DNA replication. The 
possibly deadliest type of DNA damage is DSBs, which can result in mutations, translocations, 
chromosome loss and cell death, if not repaired correctly (Hoeijmakers, 2001;Pastink et al., 2001). 
An overview of the DNA damaging agents, the DNA lesions they generate and the DNA repair 
mechanisms applied for removal of the damage is given in Figure 9. 
 
 
 
 
 
Figure 9: D"A damaging agents and repair mechanisms. (Top) The most common DNA damaging agents including the DNA-
cross-linking agents cisplatin (Cis-Pt) and mitomycin C. (Middle) Examples of DNA lesions generated by the DNA damaging agents 
including (6-4) photoproducts ((6-4)PP) and cyclobutane pyrimidine dimers (CPD). (Bottom) The most relevant DNA repair 
pathways responsible for removal of the lesions including homologous recombination (HR) and end joining (EJ) (Hoeijmakers, 
2001). 
Repair pathways 
To prevent the consequences of DNA damage on cell fate and to prevent loss of information, the 
cells have evolved a complex network of DNA repair pathways. More than 120 genes in the human 
genome have been found to be involved in repair mechanisms (Wood et al., 2005). The selection of 
repair pathway depends on the type of damage and which cell cycle phase the cell is in. The DNA 
double helix has the advantage of containing information in both strands. If one strand is damage, the 
other strand is applied as template in the repair process. This makes repair of double strand breaks 
more demanding. The different repair pathways include base excision repair (BER) which repair 
most small base modifications and nearly all oxidatively induced DNA lesions (except DSBs and 
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purine cyclonucleosides) and also SSBs (Altieri et al., 2008;Zharkov, 2008). Nucleotide excision 
repair (NER) removes photoproducts, bulky and helix distorting adducts, cross links and oxidative 
damage (Altieri et al., 2008;de Laat et al., 1999). DNA mismatch repair (MMR) maintains genetic 
integrity by correcting base substitution mismatches and insertion/deletion loop mismatches 
generated as a result of replication errors or as a result from a variety of internal and external stresses 
that escape the proofreading function of DNA polymerases (Altieri et al., 2008;Hsieh and Yamane, 
2008). Furthermore two repair pathways, homologous recombination (HR) and non-homologous end 
joining (NHEJ), repairs double strand breaks (Hoeijmakers, 2001). HR repair of broken ends is 
generally accurate because the undamaged sister chromatid is used as a repair template. This also 
restricts HR to late S and G2. NHEJ joins DNA ends without the requirement for sequence 
homology, and NHEJ and can function throughout the cell cycle, but plays an important role during 
G1, when no sister chromatid is available (Hendrickson, 1997;Khanna and Jackson, 2001).   
 
In response to DSBs, the two phosphatidyl-inositol-3-OH kinase –like kinases, ATM and ATR are 
activated and work together. The cellular response to DSBs is described in details below to illustrate 
the initial phases of the DNA damage response. 
The cellular response to D"A double strand breaks 
Cells react to DSBs by rapidly recruiting a host of proteins to the damaged chromatin regions where 
some are involved in DNA repair while others trigger signaling pathways. DSBs are believed to be 
recognized by the multifunctional Mre11-Rad50-Nbs1 (MRN) complex (Petrini and Stracker, 2003). 
The initial interaction of MRN with DSBs is transient and recruits the ATM kinase to the damaged 
DNA by interaction between the HEAT repeats of ATM and the C-terminus of Nbs1 (You et al., 
2005;Lukas et al., 2003;Falck et al., 2005). It is still at debate if it is the recruitment that activates 
ATM or ATM is already activated upon recruitment (You et al., 2005;Bakkenist and Kastan, 2003). 
In both cases, ATM is autophosphorylated very rapidly upon irradiation which causes dimer 
dissociation and initiates cellular ATM activity (Bakkenist and Kastan, 2003). The ATM-MRN 
complex triggers two main pathways to prepare the DNA for repair and to initiate checkpoint 
signaling (Bartek and Lukas, 2007) which are here described as local chromatin rearrangements and 
DSB resection. An overview of the two pathways is given in Figure 10.  
 
Local chromatin rearrangements 
In the first pathway, activated ATM phosphorylates the histone H2A variant H2AX on the conserved 
serine residue ser139 at its C-terminus. This allow the mediator protein Mdc1 to bind the 
phosphorylated H2AX (γ-H2AX) through its tandem BRCT domains (Stucki et al., 2005). Mdc1 is 
one of the first proteins to accumulate at DSB sites and is believed to be a “master regulator” by 
promoting retention of many other proteins at the site of damage (Stucki and Jackson, 2006) and 
shielding the C-terminal tail of γ-H2AX from premature dephosphorylation by phosphatases (Stucki 
et al., 2005;Stewart et al., 2003). Interaction between Mdc1 and γ-H2AX is required for efficient 
accumulation of MRN and phosphorylated ATM at sites of damage (Stucki et al., 2005;Goldberg et 
al., 2003). This facilitates other ATM dependent phosphorylation of substrates including Chk2 
(Matsuoka et al., 2000), p53 (Canman et al., 1998) and Kap1 (Ziv et al., 2006). The retention of two 
adaptor proteins 53BP1 and BRCA1 are dependent on Mdc1 without direct interaction. Mdc1 have 
been proposed to promote changes in the chromatin to allow binding of BRCA1 and allow 
accessibility of constitutively methylated residues on histones to bind 53BP1 (Bekker-Jensen et al., 
2005;Huyen et al., 2004).  
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Figure 10: D"A damage response from DSBs. DSBs are recognized by the MRN complex which recruits ATM. Activated ATM 
initiates two pathway to rearrange the chromatin to facilitate repair and checkpoint signaling. In the first pathway shown to the right 
of the figure, ATM phosphorylates histone H2AX which allow recruitment of Mdc1, MRN, ATM and activation of downstream 
targets including Chk2. The chromatin rearrangement facilitates recruitment of BRCA1 and 53BP1. In the other branch of the 
pathways, MRN and ATM facilitate resection of the DSB to allow recruitment of RPA followed by binding of ATR/ATRIP, TopBP1, 
Rad17 and Claspin. ATR is then able to activate downstream targets including Chk1 which requires Claspin (Bartek and Lukas, 
2007). 
 
BRCA1 
BRCA1 contains an N-terminal RING-finger domain and tandem BRCT (BRCA1 C-terminal) 
domains at its C-terminus. BRCA1 dimerizes through its RING-finger domain with BARD1 
(BRCA1-associated RING domain protein) to form an E3 ubiquitin ligase (Mallery et al., 2002). The 
BRCT domains are phosphoserine- or phosphothreonine-binding motifs which are also found in 
Mdc1 and 53BP1. BRCA1 is a tumor suppressor and many disease-causing mutations are detected 
within the RING and BRCT domains. Mutations in BRCA1 are associated with an increased risk of 
breast and ovarian cancer (Bochar et al., 2000).  
 
Mutations in the BRCT domains of BRCA1 disrupt its recruitment to the site of DSBs (Greenberg et 
al., 2006). The BRCT domains bind three different proteins in a mutually exclusive manner which 
are BACH1 (Cantor et al., 2001), CtIP (Yu et al., 1998) and the newly identified Abraxas (Wang et 
al., 2007). Abraxas was also found to bind Rap80 which contains a tandem ubiquitin-interacting 
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motif domain, UIM (Wang et al., 2007). Rap80 co-localize with γ-H2AX and BRCA1 at DNA 
breaks in cells exposed to IR. Abrogation of IR-induced co-localization of Rap80 UIM deletion 
mutants suggested that Rap80 gains access to double strand breaks by cooperative UIM binding to 
ubiquitin or polyubiquitin (Kim et al., 2007a;Sobhian et al., 2007;Wang et al., 2007). GST-bound 
Rap80 was found to preferentially bind K63- and possibly K6 but not K48 linked ubiquitin polymers 
(Sobhian et al., 2007). Knockdown of Mdc1 or Rap80 each reduced the intensity of BRCA1 
immunostaining at stripes and Rap80 recruitment to laser stripes was reduced in cells depleted of 
Mdc1. Together the data suggest that Rap80 recruit BRCA1 through Abraxas to ubiquitin structures 
at DSBs in an Mdc1 dependent manner. Cells depleted of Abraxas or Rap80 exhibited 
hypersensitivity to IR, G2/M checkpoint defects and defects in HR repair. The effects were less 
severe than in BRCA1 depleted cells which suggest that Abraxas and Rap80 mediate a subset of 
BRCA1 functions. Another protein found to require Rap80 for recruitment to IRIF is the DUB 
BRCC36 which is found to have DUB activity toward K63 linked ubiquitin substrates (Sobhian et 
al., 2007).    
 
53BP1 
53BP1 contains tandem BRCT domains at the C-terminus, tandem Tudor domains and several 
(S/T)Q sites in the N-terminus (Charier et al., 2004;Rappold et al., 2001). 53BP1 was first identified 
in a yeast two hybrid screen as a protein that interacts with p53 through its tandem BRCT domains 
(Iwabuchi et al., 1994). 53BP1 has key role in both DNA damage response signaling, repair of DSBs 
and is required for both IR-induced intra-S-phase and G2/M phase checkpoints (Wang et al., 2002). 
Mice deficient of 53BP1 show increased radiation sensitivity and elevated tumor risk (Morales et al., 
2003) and 53BP1 has earlier been suggested to be involved in NHEJ due to its involvement in class 
switch recombination of immunoglobulin heavy chains (Manis et al., 2004;Ward et al., 2004). 
Recently, 53BP1 was found to accumulate at deprotected telomeres and suggested to have a role in 
facilitating NHEJ repair reactions by increasing chromatin mobility that involve distant sites, 
including joining of dysfunctional telomeres (Dimitrova et al., 2008). Furthermore, 53BP1 is 
suggested to facilitate long range DNA end-joining during variable, diversity and joining (V(D)J) 
recombination (Difilippantonio et al., 2008).  
 
53BP1 rapidly accumulates at sites of DSBs and is hyperphosphorylated in an ATM dependent 
manner (Rappold et al., 2001;Schultz et al., 2000). Recruitment of 53BP1 at site of damage is 
dependent on γ-H2AX and Mdc1 but independent of Rap80 (Bekker-Jensen et al., 2005;Kim et al., 
2007a). The Tudor domains of 53BP1 have been suggested to bind methylated histone H3 or H4 to 
target 53BP1 to DSBs. Initially, 53BP1 was suggested to bind H3 lysine K79 (H3-K79) from 
biochemistry and cell biology studies. This chromatin modification exists in undamaged cells, but 
chromatin restructuring adjacent to the DSB lesion was suggested to unmask the methylated residues 
to mediate the interaction (Huyen et al., 2004). In 2006, Botuyan et al. found that both 53BP1 and 
the putative fission yeast homolog Crb2 directly bind histone H4 specifically dimethylated at K20 
(H4-K20me2) using x-ray crystallography and NMR spectroscopy. Down-regulation of the enzyme 
Dot1 responsible for H3-K79 methylation was found to have no impact on 53BP1 accumulation at 
IR induced DSBs, whereas down-regulation of PR-Set7/Set8 responsible for H4-K20 
monomethylation impaired the foci formation (Botuyan et al., 2006).  
 
DSB resection 
In the second pathway of the cellular response to DSBs, MRN and ATM also essentially initiate 
DSB resection and formation of single stranded DNA, which is essential for DNA repair by 
homologues recombination and ATR-dependent signaling (Jazayeri et al., 2005). The resection of the 
DSB requires activity of cdks and is therefore restricted to S and G2 phases of the cell cycle 
(Jazayeri et al., 2005). Upon resection of DNA, the single stranded DNA is coated and stabilized by 
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RPA which facilitates the recruitment of the ATR-ATRIP complex (Cortez et al., 2001;Zou and 
Elledge, 2003). TopBP1 is needed to reach full activation of ATR and is recruited to the ssDNA 
independently of ATR/ATRIP (Kumagai et al., 2006;Mordes et al., 2008). ATR can then activate 
most of its substrates except Chk1 which requires the mediator protein Claspin (Liu et al., 2006). 
Chk1 is a very central checkpoint kinase and phosphorylates substrates involved in regulation of cell 
cycle progression, DNA repair and apoptosis. Alongside with checkpoint activation, repair of the 
DNA by HR is initiated by formation of Rad51-nucleofilament at the ssDNA to initiate strand 
invasion.  
 
The second pathway is essentially also what is believed to happen upon detection of replication 
stress, but without resection. Upon stalling of DNA polymerases, the MCM replicative helicase is 
uncoupled from the polymerase and continue DNA unwinding ahead of the replication fork, 
generating ssDNA which binds RPA and recruits ATR through ATRIP (Byun et al., 2005). Upon 
replication block, the clamp loader Rad17 is furthermore recruited to the ssDNA and activated from 
phosphorylation by ATR (Bao et al., 2001) which then loads the Rad9-Rad1-Hus1 (911) complex 
onto DNA (Ellison and Stillman, 2003). The assembly of Claspin at the ssDNA upon replication 
stress requires activation of Rad17(Wang et al., 2006), but it is not known yet, if this is the case after 
resection of DSBs.  
 
Claspin was originally identified as a Chk1-binding protein in Xenopus egg extracts and found to be 
involved in regulating Chk1 activity (Kumagai and Dunphy, 2000). Human Claspin is nuclear and 
cell cycle regulated with peak in S/G2 and only associates with Chk1 upon replication stress or other 
types of DNA damage. Claspin becomes phosphorylated upon replication stress which is required for 
its association with Chk1 and the interaction promotes Chk1 phosphorylation by ATR. Down-
regulation of Claspin with siRNA inhibited Chk1 activation upon replication stress, abrogated 
checkpoints and decreased cell survival. Claspin was therefore suggested to have an important role in 
replication checkpoint control (Chini and Chen, 2003). Xenopus Claspin associates with replication 
forks upon origin unwinding and is found to associate with Cdc45, DNA polymerase ε, RPA and two 
replication factor C complexes on chromatin. Only transient interaction with replication forks 
potentiates Chk1 activation and the stable binding of Claspin to chromatin is suggested to have other 
roles (Lee et al., 2005).  
Spatial organization of the DDR proteins at DSBs 
The proteins involved in the DNA damage response to DSBs interact with the site of damage in a 
carefully orchestrated manner. The interaction is both timely and spatially regulated, required to 
achieve efficient checkpoint signaling and repair. The nuclear rearrangement of chromatin in 
response to IR can be observed upon formation of so-called IR-induced foci (IRIF). IRIF are 
dynamic, microscopic structures with thousands of copies of protein involved in various aspect of 
DSB repair, and are used as a convenient mark of DSB location (Bekker-Jensen et al., 2006). 
Proteins associated with IRIF participate in various repair-associated DNA transactions, but also in 
restructuring large segments of chromatin in the vicinity of the DNA lesions. This furthermore 
allows access of DNA repair factors to damaged DNA.  
 
By investigating recruitment of proteins to IRIF and studying their spatial pattern, two distinct 
regions of the IRIF can be distinguished which are the single stranded DNA (ssDNA) 
microcompartments and the DSB-flanking chromatin. Proteins interacting with the DSB-flanking 
chromatin assemble within the entire regions of modified chromatin that surrounds the DNA breaks 
and spans up to a megabase distance from the initial DSB lesion (Figure 11A). In the ssDNA 
microcompartment proteins assemble in much smaller areas called microfoci (Figure 11B). Unlike 
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the chromatin mediated interactions, assembly of proteins in the ssDNA microcompartments is 
restricted to S and G2 due to DSB resection (Bekker-Jensen et al., 2006).         
 
A. B. 
  
 
Figure 11: Spatial organization of DDR proteins at DSBs. (A) Proteins interacting with the DSB-flanking chromatin include 
Mdc1, 53BP1 and ATM. To visualize their interaction with chromatin, U2OS cells were sensitized with BrdU and microirradiated. 1 
hour later, the cells were fixed and stained with antibodies against the indicated proteins and their co-localization with γ-H2AX show 
almost complete overlap (indicated by yellow from a merge of the two pictures). (B) Proteins interacting only with the subchromatin 
microfoci include Rad51, RPA and ATRIP. The cells were treated as in A. and from their merged pictures, only a slight overlap with 
γ-H2Ax is observed which indicates the microfoci (Bekker-Jensen et al., 2006). 
 
Proteins assembling at DSB-flanking chromatin include ATM, 53BP1 and Mdc1, whereas proteins 
assembling in microfoci include ATR, ATRIP, RPA, Rad51 and FANCD2. A striking feature of 
BRCA1 is to interact with both the DSB-flanking chromatin region throughout interphase and at 
microfoci in S and G2. Only the chromatin bound and not ssDNA associated retention of BRCA1 is 
controlled by Mdc1 (Bekker-Jensen et al., 2006). This can be observed in cells treated with siRNA 
against Mdc1. In these cells, BRCA1 only accumulates at microfoci and not at chromatin which is 
marked by γ-H2AX (Figure 12A and B). IRIF formation of 53BP1 on the other hand is completely 
dependent on Mdc1 and occurs only at the DSB-flanking chromatin. See Figure 12B.  
 
A. B. 
  
 
Figure 12: BRCA1 assembly at DSB-flanking chromatin and at microfoci. (A) To visualize the interaction of BRCA1 with 
chromatin, the cells were treated with siRNA as indicated before treatment as described in Figure 11A. The assembly of BRCA1 to 
DBS-flanking chromatin can be observed from the co-localization with γ-H2AX which is abrogated when treating the cells with 
siRNA against Mdc1. Only assembly at microfoci remains. (B) The cells were treated with siRNA as in A. before treatment 
described in Figure 11A. 53BP1 assembly is abrogated in Mdc1 siRNA treated cells in contrast to BRCA1 which still assembles at 
microfoci along the microirradiated track (Bekker-Jensen et al., 2006). 
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D"A damage checkpoints 
DNA damage checkpoints are activated upon exposure to genotoxic insults which affects completion 
of a cell cycle phase. The pathways, which are also described above, include sensor proteins that 
monitor the presence of abnormalities in the DNA and help signaling to signal transducers and 
mediators which amplify and propagate the signal to downstream effectors that connect the 
checkpoint with the core cell cycle machinery. Different pathways are activated depending on the 
type of DNA damage and in which cell cycle phase the cell is in when the damage occur (Lukas et 
al., 2004).    
 
G1/S 
To prevent entering S-phase with damaged DNA and subsequent propagation of potentially 
hazardous mutations, cells facing DNA damage in G1 activate the checkpoint transducing kinases 
ATM/ATR and Chk1/Chk2 to delay or arrest cell cycle progression through two distinct pathways. 
The first involves the Cdc25A phosphatase and the second involves the transcription factor p53 
(Bartek and Lukas, 2001;Lukas et al., 2004). Phosphorylation of Cdc25A and p53 by Chk1/Chk2 
occurs rapidly and simultaneous, but the effect of the Cdc25A pathway is fast compared to the effect 
of the p53 pathway. Phosphorylation of Cdc25A mediates its ubiquitylation by SCF
βTrCP
 and 
degradation by the proteasome, which prevents activating dephosphorylation of Cdk2 and eventually 
prevents initiation of DNA synthesis (Busino et al., 2003). The Cdc25A pathway is relatively 
transient and p53 is necessary to achieve a sustained arrest in G1. p53 is phosphorylated by 
Chk1/Chk2 but also directly by ATM/ATR which furthermore targets the p53 ubiquitin ligase 
Mdm2. Collectively, this allow stabilization, accumulation and activation of p53 resulting in 
transcription of p53 targets including p21 which inhibits cdks. The fast and transient Cdc25A 
pathway is hereby replaced by the p53 pathway to keep a prolonged G1 arrest (Bartek and Lukas, 
2001;Lukas et al., 2004). 
 
Intra S 
The checkpoint induced upon genotoxic stress during DNA replication causes only transient and 
reversible delay of the cell cycle progression. The intra-S checkpoint mainly inhibits initiation of 
unfired origins and thereby slows down replication. If the damage is not repaired during this delay, 
the cells will continue S phase, but with slower rate, and arrest later when reaching the G2/M 
checkpoint. The checkpoint operates mainly through the Cdc25A pathway as described above and is 
independent on p53. A multitude of other proteins are found to be involved and the exact mechanism 
of the checkpoint remains obscure (Bartek et al., 2004;Lukas et al., 2004).  
 
G2/M  
The G2/M checkpoint prevents cells from entering mitosis in the presence of damaged DNA. The 
checkpoint is activated both upon DNA damage encountered during G2 but also damage sustained 
from S phase. The key downstream target of this checkpoint is major mitosis promoting activity of 
Cyclin B-Cdk1 (Lukas et al., 2004;van Vugt and Medema, 2005). The checkpoint kinases 
ATM/ATR activates Chk1 and Chk2 which results in inactivation of all three Cdc25 phosphatases 
(A, B and C) that normally activates Cdk1 at entry into mitosis. The phosphatases are inactivated 
either through inhibitory phosphorylation or via ubiquitin-mediated degradation (Donzelli and 
Draetta, 2003). Chk1 has been proposed to phosphorylate Cdc25C at Ser216 to prevent its activation 
by sequestering Cdc25C in the cytoplasm through binding to 14-3-3 proteins (Sanchez et al., 
1997;Peng et al., 1997). Also Cdc25B has been suggested to bind 14-3-3 upon phosphorylation by 
p38 in vitro to restrict Cdc25B to the cytoplasm (Bulavin et al., 2001). A subset of Chk1 has 
furthermore been suggested to localize at interphase centrosomes and appears to shield centrosomal 
Cdk1 from unscheduled activation by Cdc25B to restrain mitotic onset (Krämer et al., 2004). 
Phosphorylation of Cdc25A by Chk1 triggers SCF
βTrCP
 mediated ubiquitylation of Cdc25A followed 
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by rapid proteasomal degradation as described above. The degradation of Cdc25A together with 
sequestering Cdc25B and Cdc25C away keeps Cyclin B-Cdk1in its inactive state thus blocking the 
G2/M transition. In Xenopus, Chk1 furthermore inhibit the cell cycle progression by activating 
Wee1, which is a negative regulator of Cdk1 (Lee et al., 2001). Also Plk1 was shown to be a direct 
target of the G2/M checkpoint (Smits et al., 2000a) and its catalytic inhibition was shown to be 
dependent on ATM/ATR (van Vugt et al., 2001). Furthermore, the phosphatase Cdc14B is suggested 
to translocate from the nucleolus to the nucleoplasm, upon DNA damage encountered in G2, and 
induce activation of APC
Cdh1
 which degrades Plk1. Degradation of Plk1 stabilizes Claspin and Wee1 
to allow efficient G2/M checkpoint (Bassermann et al., 2008). Since Claspin is also a target of 
APC
Cdh1
 which has been shown in G0 and G1, USP28 is suggested to stabilize Claspin from APC
Cdh1
 
mediated degradation in response to DNA damage (Bassermann et al., 2008). I addition, p53 is 
involved in the G2/M arrest by activating transcription of p21 which blocks the activating 
phosphorylation of Cdk1 on Thr161. This p53 mediated arrest is like in the G1/S arrest slower and is 
proposed to achieve a sustained G2 arrest in response to DNA damage (Smits et al., 2000b). 
Recovery from G2/M 
In Xenopus egg extracts with aphidicolin-induced (polymerase α inhibitor) DNA replication blocks, 
Claspin becomes phosphorylated on Thr906, which promotes its interaction with and 
phosphorylation of Ser934 by Plx1, a Xenopus Polo-like kinase. After prolonged interphase arrest, 
the extracts typically undergo adaptation and enter mitosis despite the presence of incompletely 
repaired DNA, resulting in a dissociation of Claspin from chromatin and inactivation of Chk1. 
Experiments with Claspin mutants unable to be phosphorylated, Claspin accumulated at chromatin 
and Chk1 activation was sustained and the extracts were not able to undergo adaptation. Plx1 was 
therefore suggested to be involved in terminating of a replication checkpoint response by inactivating 
Claspin (Yoo et al., 2004). Indeed, Plk1 was found to be critically required for recovery from a G2 
checkpoint arrest in mammalian cells (van Vugt et al., 2004). Yet Claspin dissociation from 
chromatin in Xenopus is altered to Claspin degradation in mammalian cells as described below.  
 
At the onset of mitosis in human cells, Claspin becomes degraded. Plk1 was found to prime Claspin 
for degradation by phosphorylating Ser30 and Ser34 of Claspin, leading to its recognition and 
ubiquitylation by SCF
βTrCP
. The degradation of Claspin was found to be dependent on an N-terminal 
βTrCP binding motif, DSGXXS. Impaired phosphorylation of the binding motif or down-regulation 
of βTrCP stabilized Claspin in mitosis, impaired Chk1 dephosphorylation and delayed entry into 
mitosis during recovery from cell cycle arrest imposed by DNA damage or replication stress 
(Mailand et al., 2006;Mamely et al., 2006;Peschiaroli et al., 2006). Undegraded Claspin in cells after 
passing the G2/M checkpoint allowed partial reactivation of Chk1 in cells exposed to DNA damage. 
Degradation of Claspin was therefore suggested to facilitate timely reversal of the checkpoint 
response and define the period permissive for Chk1 activation during cell cycle progression (Mailand 
et al., 2006).  
 
Degradation of Claspin accumulates Cdc25A due to inactivation of Chk1 and Cdc25A then 
dephosphorylates and activate Cdk1 and Cdk2. The increase in Cdk1 activity is suggested to 
phosphorylate Wee1 to prime Wee1 for Plk1 phosphorylation which recruits SCF
βTrCP
 and results in 
ubiquitylation and degradation. This furthermore increases the Cdk1 activity to allow cells to resume 
cell cycle progression and enter mitosis (Watanabe et al., 2004). An overview of checkpoint 
initiation and recovery can be observed in Figure 13. Interestingly SCF
βTrCP
 function as a molecular 
switch, from Cdc25A degradation upon checkpoint initiation to Claspin and Wee1 degradation upon 
checkpoint recovery. It appears that it is the phosphorylation state of Cdc25A, Claspin and Wee1 that 
allows SCF
βTrCP
 to change its target (Bartek and Lukas, 2007). 
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Figure 13: Checkpoint initiation and recovery. Upon checkpoint initiation, ATR becomes activated and phosporylates Chk1 in a 
Claspin dependent manner. Chk1 phosphorylation of Cdc25A primes the phosphatase for degradation by the SCFβTrCP ubiquitin 
ligase which keeps Cdk1 and Cdk2 in their inactive phosphorylated state which arrest the cells in G2. Upon checkpoint recovery 
when the damage is repaired, Plk1 phosphorylates Claspin which targets the protein for degradation by the SCFβTrCP complex. The 
increase in the phosphatase activity of Cdc25A together with lower inhibiting phosphorylation activity of Wee1, which is also 
targeted for degradation allows activation of Cdk1 and Cdk2, and the cell can continue cell cycle progression and enter mitosis  
(Bartek and Lukas, 2007). 
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4 Results and Discussion 
 
Upon exposure to genotoxic agents, efficient repair of DNA damage is coordinated with the cell 
cycle to ensure low occurrence of mutations, chromosomal translocations and chromosome loss, to 
preserve the integrity of the genome. The aim of this PhD thesis is to increase our knowledge on how 
cells apply ubiquitylation to co-ordinate these responses to DNA damage efficiently.  
 
In the Results and Discussion part, the two main projects, I have been working on during my PhD, 
are presented. Each project will be presented separately and includes the original publication or 
manuscript in press, followed by a discussion which relates the obtained data to earlier and later 
findings. The supplemental data of each publication is given in the appendix.  
 
In the first project, the novel role of the RNF8 ubiquitin ligase in the DNA damage response is 
presented. RNF8 was found to accumulate at DSB-flanking chromatin upon DNA damage through 
binding to Mdc1 and ubiquitylate histones to facilitate recruitment of 53BP1 and BRCA1 to sites of 
damage. In the second project, the novel role of the deubiquitylating enzyme USP7 in maintaining 
steady-state levels of Claspin is presented. Claspin was furthermore found to be degraded by 
APC
Cdh1
 in G1 and USP7 was found to oppose the SCF
βTrCP
- but not the APC
Cdh1
-mediated 
degradation of Claspin. 
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SUMMARY
Accumulation of repair proteins on damaged
chromosomes is required to restore genomic
integrity. However, the mechanisms of protein
retention at the most destructive chromosomal
lesions, the DNA double-strand breaks (DSBs),
are poorly understood. We show that RNF8,
a RING-finger ubiquitin ligase, rapidly assem-
bles at DSBs via interaction of its FHA domain
with the phosphorylated adaptor proteinMDC1.
This is accompanied by an increase in DSB-
associated ubiquitylations and followed by
accumulation of 53BP1 and BRCA1 repair pro-
teins. Knockdown of RNF8 or disruption of its
FHA or RING domains impaired DSB-associ-
ated ubiquitylation and inhibited retention of
53BP1 and BRCA1 at the DSB sites. In addition,
we show that RNF8 can ubiquitylate histone
H2A and H2AX, and that its depletion sensitizes
cells to ionizing radiation. These data suggest
that MDC1-mediated and RNF8-executed his-
tone ubiquitylation protects genome integrity
by licensing the DSB-flanking chromatin to con-
centrate repair factors near the DNA lesions.
INTRODUCTION
Among the most prominent cytological manifestations of
DNA breakage is formation of the ionizing radiation-
induced foci (IRIF). These nuclear structures reflect local
chromatin expansion, posttranslational modifications of
histones, and assembly of diverse proteins in the vicinity
of chromosomal lesions (Fernandez-Capetillo et al., 2004;
Kruhlak et al., 2006). In mammals, phosphorylation of
histone H2AX (g-H2AX) by the ATM kinase is among the
most proximal DSB-induced histone modifications and
the prerequisite for the sustained retention of signaling
and repair proteins. Specifically, the proteins that avidly
accumulate on the g-H2AX-marked chromatin include
the components of theMRE11-NBS1-RAD50 (MRN) com-
plex, the ATM kinase, and a group of large adaptor pro-
teins such as MDC1, 53BP1, and BRCA1 (Bekker-Jensen
et al., 2006). The increased concentration of these pro-
teins is believed to enhance the effectiveness of genome
surveillance mechanisms by amplifying ATM signaling
and increasing the efficiency of DSB repair (Lukas et al.,
2004b).
The assembly of proteins at the DSB-flanking chromatin
proceeds with distinct temporal patterns, suggesting that
the formation of the DSB-induced chromatin microenvi-
ronment is a hierarchical and highly regulated process
(Bekker-Jensen et al., 2005; Lukas et al., 2004a). The
key interaction module engaged in direct binding to
g-H2AX resides in the BRCT domains of MDC1 (Stucki
et al., 2005). MDC1 is among the first proteins to accumu-
late at the DSB sites (Lukas et al., 2004a), and the assem-
bly of the g-H2AX-MDC1 complex seems to be required
for retention ofmost other proteins in these regions (Stucki
and Jackson, 2006). Furthermore, MDC1 binding shields
the C-terminal tail of g-H2AX against premature dephos-
phorylation (Stewart et al., 2003; Stucki et al., 2005),
a feature that helpsmaintain a favorable chromatin config-
uration until the completion of the DSB repair. Thus,
MDC1 emerges as the ‘‘master regulator’’ determining
the formation of a specific chromatin microenvironment
required for genomic stability.
The way MDC1 promotes chromatin retention of other
proteins involves at least two distinct mechanisms. First,
there is biochemical evidence that the retention of NBS1
at the DSB-flanking chromatin is mediated by its direct
interaction with MDC1 (Goldberg et al., 2003; Lukas
et al., 2004a; Stewart et al., 2003). Real-time imaging of liv-
ing cells supports this model by showing that MDC1 and
NBS1 accumulate at the DSB-flanking chromatin very
rapidly and with the same kinetics (Lukas et al., 2004a).
Because NBS1 also directly binds ATM (Falck et al.,
2005; You et al., 2005), the MDC1-mediated retention of
NBS1 has a crucial physiological significance for the initial
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stages of the DSB response as it promotes spreading of
g-H2AX from the initial breakage sites and facilitates other
ATM-dependent phosphorylations (Stucki and Jackson,
2006). Second, although the retention of 53BP1 at the
DSB sites is also dependent on MDC1, its accumulation
at the DSB-flanking chromatin is significantly delayed
(Bekker-Jensen et al., 2005). Based on this observation,
and the fact that 53BP1 interacts with DSBs via binding
to constitutively methylated residues on histones (Bo-
tuyan et al., 2006; Huyen et al., 2004), it has been pro-
posed that MDC1 promotes higher-order chromatin
restructuring that may increase the accessibility of histone
marks. Alternatively, the formation of the g-H2AX-MDC1
complex may promote additional modifications of the
DSB-flanking chromatin that in conjunction with methyl-
ated histones increase the affinity for 53BP1.
Although intriguing, our understanding of the dynamics
(and indeed the purpose) of the DSB-induced chromatin
response is only rudimentary, and the above concepts
leave several unanswered questions. Most notably,
although it has been shown that the MDC1-NBS1 interac-
tion requires the intact FHA domain of the latter protein
(Lukas et al., 2004a), the exact structural requirements
for this interaction are not understood, and whether other
proteins accumulate at the DSB sites via direct binding to
MDC1 has not been determined. Even more elusive are
the structural and/or posttranslational events that operate
between the rapid assembly of the g-H2AX-MDC1 com-
plexes and the delayed accumulation of 53BP1. Finally,
chromatin retention of BRCA1 is also regulated by MDC1
(Bekker-Jensen et al., 2006; Lou et al., 2003) and requires
at least two additional proteins, RAP80 and ABRA1 (Kim
et al., 2007; Sobhian et al., 2007; Wang et al., 2007; Yan
et al., 2007). However, how MDC1 functionally interacts
with the RAP80-ABRA1 complex to regulate chromatin
retention of BRCA1 remains an outstanding puzzle in the
biology of this important tumor suppressor. In this study,
we attempted to resolve these issues.
RESULTS
RNF8 Is a Novel DSB Regulator, which Binds
to Chromatin in an MDC1-Dependent Manner
We performed a bioinformatic search for proteins that
contain structural motifs shared by the established DSB
regulators and tested their ability to accumulate at the
DSB-modified chromatin. By this approach, we identified
RNF8, a member of the RING-finger-containing nuclear
factors (Ito et al., 2001; Plans et al., 2006), which contains
a phosphothreonyl-binding FHA domain at its N terminus
and a RING-finger domain at the C terminus (Figure 1A).
Both domains have been previously identified in chroma-
tin-associated DSB regulators such as NBS1 and MDC1
(the FHA domain) (Stracker et al., 2004; Stucki and Jack-
son, 2006) or the BRCA1-BARD1 complex (the RING
domain) (Boulton, 2006). Importantly, both green fluores-
cence protein (GFP)-tagged RNF8 (Figures S1A and S1B)
and endogenous RNF8 avidly accumulated in IRIF and in
microlaser-generated DSB tracks, respectively (Figures
1B–1E), and several pieces of evidence indicated that
this DNA damage-induced accumulation reflected target-
ing of RNF8 to the DSB-flanking chromatin. Thus, GFP-
RNF8 spanned the entire chromatin regions marked by
g-H2AX (Figure 1C, left). In addition, GFP-RNF8 accumula-
tion at the DSBs was equally robust throughout interphase
(Figure 1C, right), a feature shared by all known compo-
nents of the DSB-flanking chromatin (Bekker-Jensen
et al., 2006). Butmost significantly, the DSB-induced accu-
mulation of RNF8 was abrogated after siRNA-mediated
ablation of MDC1, the key upstream regulator of the
DSB-induced chromatin response (Figure 1F). Together,
these data suggest that RNF8 is a new DSB regulator
that interacts with the DSB-flanking chromatin.
The FHA Domain of RNF8 Binds
Phosphorylated MDC1
To elucidate how RNF8 interacts with the DSB sites, we
asked whether it binds MDC1. Indeed, endogenous RNF8
and MDC1 interacted in a coimmunoprecipitation assay
(Figure 2A), and we set out to explore the structural basis
of this interaction. While the wild-type (WT) and RING-
deficient (C403S; *RING) versions of RNF8 bound MDC1
(Figure 2B), a point mutation of a conserved residue within
the FHA domain of RNF8 (R42A; *FHA) abolished the inter-
action (Figure 2B). Consistently, the GFP-tagged *FHA
version of RNF8 failed to form nuclear foci after ionizing
radiation (IR), whereas the wild-type protein or the *RING
mutant avidly accumulated at DSBs (Figure 2C). We then
performed a deletion analysis of the MDC1 N terminus
and found that the region between amino acids 698 and
800 was necessary and sufficient for RNF8 binding
(Figure S2A). This region of MDC1 contains three con-
served T-Q-X-F clusters (Figure S2B) fulfilling the criteria
for ATM/ATR substrates (Shiloh, 2003).While single or dou-
ble substitutions of the threonine residueswith alanines had
little effect on binding of MDC1 to RNF8 (our unpublished
data), simultaneous threoninemutations in all three clusters
(designated as 3A) completely abolished this interaction
(Figure 2D). To validate that the T-Q-X-F clusters could
be phosphorylated in vivo, we exposed cells expressing
the wild-type or the 3A fragments of MDC1 to IR and ana-
lyzed the immunopurified MDC1 proteins by immunoblot-
ting with an antibody to phosphorylated SQ/TQ motifs
(the consensus sites for ATM/ATR targets). Although wild-
type MDC1 was phosphorylated to some extent even in
nonirradiated cells (likely due to the low intrinsic ATM/
ATRactivity), this phosphorylationmarkedly increased after
exposing the cells to IR, and mutation of the T-Q-X-F clus-
ters impaired both the basal and the IR-induced phosphor-
ylation of MDC1 (Figure 2E). Consistently, while FLAG-
RNF8 and endogenous MDC1 interacted to some extent
in unstressed cells, this interaction was enhanced after IR
(Figure 2F). Together, these data suggest that phosphoryla-
tion of the conserved T-Q-X-F clusters of MDC1 and the
integrity of the FHA domain of RNF8 are required to medi-
ate the interaction between these two proteins.
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Phosphorylation of MDC1 Determines Retention
of RNF8 at the DSB Sites
To test the significance of the MDC1-RNF8 interaction
directly in cells, we downregulated endogenous MDC1
by shRNA (Bekker-Jensen et al., 2006) and reintroduced
into these cells either WT or the 3A version of MDC1
(both full-length and resistant to the shRNA) together
with GFP-RNF8. As expected, the MDC1 knockdown
abolished accumulation of GFP-RNF8 at the sites of DNA
damage (Figure 2G, top). Strikingly, although MDC1-WT
Figure 1. Accumulation of RNF8 at the DSB Sites Is Regulated by MDC1
(A) Schematic structure of human RNF8. Positions of residues mutated to generate RNF8 *FHA (R42A) and RNF8 *RING (C403S) are indicated.
(B) U-2-OS cells stably expressing GFP-RNF8 (U-2-OS/GFP-RNF8) before (left) and 30 min after (right) exposure to IR (4 Gy) were immunostained for
g-H2AX.
(C) U-2-OS/GFP-RNF8 cells were microirradiated and after 30 min immunostained for g-H2AX (left) or for cyclin B1 (right). RNF8 accumulates at laser
tracks regardless of cyclin B1, indicating that its interaction with the DSB sites is cell cycle independent.
(D) U-2-OS cells conditionally expressing shRNA to RNF8 (U-2-OS/shRNF8) cells were induced or not with Doxycycline (Dox) for 48 hr and analyzed
by immunoblotting with a rabbit antibody to RNF8.
(E) U-2-OS/shRNF8 cells were induced or not with Dox for 48 hr, exposed to laser microirradiation, and 1 hr later coimmunostained with antibodies to
RNF8 and g-H2AX. WCE, whole-cell extract; scale bar, 10 mm.
(F) U-2-OS/GFP-RNF8 cells were transfected with the indicated siRNA oligonucleotides for 96 hr, microirradiated as in (C), and immunostained for g-
H2AX. Scale bars, 10 mm.
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Figure 2. The FHA Domain of RNF8 Interacts with Phosphorylated MDC1
(A) Lysates from HEK293T cells were immunoprecipitated with control or RNF8-specific antibodies followed by immunoblotting with antibody to
MDC1.
(B) HEK293T cells were cotransfected with the HA-tagged N-terminal fragment of MDC1 (amino acids 1–1100) and the indicated versions of FLAG-
RNF8. Interactions between MDC1 and RNF8 were assessed by immunoprecipitation (IP) of HA-tagged proteins followed by immunoblotting with
anti-FLAG antibody.
(C) U-2-OS cells stably expressing wild-type (WT), FHA-deficient (*FHA), or RING-deficient (*RING) forms of GFP-RNF8 were left untreated (top) or
exposed to 4 Gy of IR (bottom). Images were acquired after 30 min.
(D) HEK293T cells were cotransfected with indicated combinations of plasmids, and association between RNF8 and MDC1 was analyzed by coim-
munoprecipitation as in (A).
(E) HEK293T cells transfected with HA-taggedWT or 3A fragments of MDC1 (1–1100) were exposed or not to IR (10 Gy). One hour later, the extent of
MDC1 phosphorylation was assayed by immunoprecipitation with anti-HA antibody followed by immunoblotting with the phospho-SQ/TQ antibody.
MCM6 is a loading control. WCE, whole-cell extract.
(F) U-2-OS cells were transfected with FLAG-RNF8 and exposed or not to IR (10 Gy). One hour later, binding between ectopic RNF8 and endogenous
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and MDC1-3A were expressed to similar levels (Fig-
ure S3A) and formed readily discernible IR-induced foci
(Figure 2G, bottom), only the WT protein was able to
restore GFP-RNF8 accumulation at the DSB sites (Fig-
ure 2G, bottom). Interestingly, while mutation of the T-Q-
X-F clusters completely uncoupled MDC1 from RNF8
(Figures 2D and 2G), the sameMDC1-3Amutant remained
fully proficient to interact with NBS1 (Figure S3B) and sup-
port NBS1 focus formation (Figure S3C). Because NBS1
alsocontains anFHAdomain,which is required for its inter-
action with MDC1 and accumulation at the DSB sites (Lu-
kas et al., 2004a), these data support the emerging con-
cept of MDC1 as a molecular matchmaker capable of
organizing multiple signaling and repair factors in the
vicinity of DNA breaks and suggest that the main purpose
of theATM-mediated phosphorylation of the T-Q-X-F clus-
ters is to recruit RNF8.
RNF8 Rapidly Assembles at the DSB-Flanking
Chromatin
To investigate the function of RNF8 at the sites of DNA
damage, we applied a kinetic assay based on micro-
laser-generated DSBs coupled with a real-time imaging
of protein redistribution (Bekker-Jensen et al., 2006; Lu-
kas et al., 2003). By this approach, we found that the
accumulation of GFP-RNF8 in the microirradiated regions
was extremely rapid: the first signs of local concentration
of GFP-RNF8 were detectable in less than a minute, and
the steady-state accumulation in the DSB areas was
reached between 6 and 8 min after microirradiation
(Figure 3A, top). We noticed that while the assembly kinet-
ics of GFP-RNF8 was similar to that of GFP-MDC1
(Figure 3A, middle), it appeared faster than the accumula-
tion of GFP-BRCA1 (Figures 3A, bottom and S1C). This
prompted us to compare the kinetic parameters of all
core components of the DSB-flanking chromatin under
strictly identical conditions (Bekker-Jensen et al., 2005,
2006; Lukas et al., 2004a). A quantitative analysis of the
fluorescence intensities of MDC1, NBS1, 53BP1, BRCA1,
and RNF8 (all GFP-tagged, stably expressed in an isogenic
parental cell line, and tested for their functionality)
revealed that their accumulation at the DSB-flanking chro-
matin clusters into two distinct kinetic groups: the ‘‘early’’
group comprising MDC1, NBS1, and RNF8, followed by
the ‘‘late’’ group including 53BP1 and BRCA1 (Figure 3B).
The delayed assembly of BRCA1 was confirmed at the
level of endogenous proteins by comparing its accumula-
tion with that of 53BP1, the known late component of the
DSB-modified chromatin (Bekker-Jensen et al., 2005)
(Figure S4A). Conversely, we found that endogenous
RNF8 accumulated at the DSB sites as early as MDC1,
themost upstream protein to arrive at the g-H2AX-marked
chromatin (Figure S4B). Finally, the assembly of ATR,
a protein that specifically interacts with single-stranded
DNA generated by DSB resection (Cortez et al., 2001;
Bekker-Jensen et al., 2006), was significantly delayed
compared to both early and late chromatin assembly
waves (Figure 3B), suggesting that the chromatin re-
sponse in general precedes the DNA-end resection.
Collectively, these results demonstrated that our experi-
mental conditions were sensitive enough to temporally
dissect the DSB-induced chromatin formation, and that
RNF8 is among the first proteins to assemble in this
compartment.
A Ubiquitin-Regulated Event Couples the Rapid
and Delayed Accumulation of Proteins
at the DSB-Modified Chromatin
The finding that the accumulation of 53BP1 and BRCA1 at
DSBs was delayed, dependent on MDC1 (Bekker-Jensen
et al., 2005, 2006; Lou et al., 2003) yet each independent
of the other (Figure S5), suggested that both 53BP1 and
BRCA1 share a common, MDC1-regulated denominator
required for their productive retention in the DSB-flanking
chromatin. Since RNF8 binds MDC1, accumulates rapidly
at the DSB sites, and contains a RING domain typical for
the E3 ubiquitin ligases (Ito et al., 2001; Plans et al.,
2006), we reasoned that it, and its enzymatic activity,
might couple the assembly of MDC1 with the ensuing
accumulation of 53BP1 and BRCA1.
To test this hypothesis, we first asked whether regula-
tory ubiquitylation as such contributes to the accumula-
tion of DSB regulators on the DNAdamage-modified chro-
matin. We exploited the recent findings showing that
inhibition of the 26S proteasome causes a rapid depletion
of free nuclear ubiquitin due to accumulation of nonde-
graded polyubiquitylated proteins in the cytosol (Dantuma
et al., 2006). Indeed, also in our cellular system protea-
some inhibitors such as MG132 triggered progressive
translocation of GFP-ubiquitin, as well as the ubiquitin-
protein conjugates, from the nucleus to the cytoplasm,
a process that was completed between 60 and 90 min
after MG132 addition (Figure S6A). This was accompanied
by a loss of monoubiquitylated histones (Figure S6B), con-
firming a severe impairment of regulatory ubiquitylations in
the nucleus (Dantuma et al., 2006). Strikingly, such deple-
tion of free nuclear ubiquitin had a very differential impact
on the ability of proteins to accumulate at the DSB-flank-
ing chromatin. When cells were pretreated with MG132
and then subjected to laser microirradiation, the pattern
and extent of the g-H2AX-decorated chromatin devel-
oped normally, and MDC1, NBS1, and RNF8 (the early
MDC1wasmonitored by immunoprecipitation with anti-FLAG antibody followed by immunoblotting with anti-MDC1 antibody (the lower MDC1 signal
in lane 3 is due to increased chromatin retention of MDC1 after DNA damage). Asterisk indicates a crossreacting band.
(G) U-2-OS cells, or their derivatives stably expressing the MDC1-targeting shRNA (U-2-OS/shMDC1), were transiently transfected with GFP-RNF8
and exposed to IR (4 Gy, 30 min). The ability of GFP-RNF8 to form IR-induced foci was monitored by confocal microscopy (top). U-2-OS/shMDC1
cells were cotransfected with GFP-RNF8 and the indicated versions of HA-taggedMDC1 (all in the context of full-length MDC1), exposed to IR (4 Gy,
30 min), and immunostained with anti-HA antibody (bottom). Scale bars, 10 mm.
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kinetic group) accumulated at the DSB sites (Figure 3C,
top panels). In contrast, the accumulation of BRCA1 and
53BP1 (the late kinetic group) was abrogated under these
conditions (Figure 3C, bottom panels). Consistently, when
assayed in cells that had been first microirradiated and
only then challenged with MG132, 53BP1 (the late assem-
bly group) but not NBS1 (the early assembly group) disso-
ciated from the microirradiated compartments with the
kinetics that mirrored the pace of the nuclear ubiquitin de-
pletion (Figure S6A). Thus, while regulatory ubiquitylation
is not required for the initial DSB-induced chromatin
response, it appears essential for generating conditions
permissive for the second wave of protein accumulation.
RNF8 Ubiquitylates the DSB-Flanking Chromatin
and Promotes Accumulation of 53BP1 and BRCA1
in This Compartment
We then designed two independent RNF8-targeting
siRNA oligonucleotides, each of which efficiently downre-
gulated RNF8 (Figure S7A). Strikingly, RNF8 knockdown
essentially recapitulated chemical depletion of the free
nuclear ubiquitin by allowing normal assembly of MDC1
and NBS1 (Figure 4A, left panels) but preventing accumu-
lation of 53BP1 and BRCA1 at the DSB-flanking chromatin
(Figure 4A, right panels). The residual BRCA1 retention in
themicroirradiated regions was not unexpected given that
a fraction of BRCA1 directly binds DNA (Paull et al., 2001),
and that this type of interaction is independent of chroma-
tin (Bekker-Jensen et al., 2006). Larger magnification
confirmed that the RNF8 knockdown reduced BRCA1
accumulation to small subchromatin ‘‘microfoci’’ typical
for ssDNA-binding proteins (Figure 4A, insets). Indepen-
dent experiments confirmed that downregulation of
RNF8 did not prevent DSB resection and formation of
the RPA-coated ssDNA compartments (Figure S7B).
Consistent with earlier studies reporting local ubiquity-
lation in the IR-induced nuclear foci (Morris and Solomon,
2004; Polanowska et al., 2006) we noticed that laser mi-
croirradiation induced local accumulation of conjugated
ubiquitin (Figure 4B). Remarkably, this was drastically im-
paired both by depletion of nuclear ubiquitin (achieved by
a short treatment with MG132 before microirradiation) and
Figure 3. Protein Assembly at the DSB-Flanking Chromatin Follows Two Distinct Temporal Waves
(A) U-2-OS cell lines stably expressing the indicated GFP-tagged proteins were exposed to laser microirradiation followed by a real-time recording of
the protein assembly kinetics.
(B) U-2-OS cell lines were assayed as in (A). The fluorescence intensity values in the microirradiated areas were pooled from 10 independent cells per
each protein and plotted on a time scale. NFU, normalized fluorescence units. Error bars represent twice the standard error of the normalized data at
the respective time points.
(C) U-2-OS/GFP-RNF8 cells (top) or the parental U-2-OS cells (the remaining panels) were incubated for 90 min with MG132, microirradiated by the
laser, and after an additional 30 min immunostained with the indicated antibodies. Scale bars, 10 mm.
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by siRNA-mediated knockdown of RNF8 (Figure 4B).
Although knockdown of BRCA1 also reduced the DSB-
associated accumulation of conjugated ubiquitin as previ-
ously reported (Morris and Solomon, 2004; Polanowska
et al., 2006), the effect of RNF8 was consistently much
more dramatic (Figures 4B, S8A, and S8B) and compara-
ble to that achieved by depletion of MDC1, themediator of
RNF8 recruitment to theDSB-flanking chromatin (Figure 4B).
Together, these data suggest that the RNF8 ubiquitin ligase
directly contributes to DSB-induced ubiquitylations that in
turn function as an important trigger for 53BP1 and
BRCA1 retention in the neighboring chromatin. In support
of this conclusion, knockdown of RNF8 abrogated DSB
retention of RAP80 (Figure 5A), a ubiquitin-binding protein
that is essential for BRCA1 recruitment to the DSB sites
(see Introduction). Interestingly, RNF8 remained associ-
ated with the DSB sites as long as these were marked by
g-H2AX (Figure S4C), suggesting that its activity facilitates
accumulation of BRCA1 and 53BP1 in the vicinity of DNA
breaks until these are productively repaired.
Figure 4. Knockdown of RNF8 Impairs Accumulation of 53BP1, BRCA1, and Conjugated Ubiquitin at the DSB-Flanking Chromatin
(A) U-2-OS cells were transfected with control or RNF8-targeting siRNA oligonucleotides, microirradiated, and 1 hr later immunostained with the
indicated antibodies.
(B) U-2-OS cells were transfected with the indicated siRNA oligonucleotides or treated for 90minwithMG132 as indicated,microirradiated, incubated
for 1 hr, and coimmunostained with antibodies to conjugated ubiquitin (FK2) and g-H2AX. Scale bars, 10 mm.
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To test the impact of RNF8 on the DSB-induced chroma-
tinmaturation in vivo, we generated cell lines allowing a con-
ditional replacement of the endogenous RNF8 by the WT,
*FHA, or *RING versions of RNF8 achieved by a doxycy-
cline-dependent induction of the RNF8-targeting shRNA
combined with a simultaneous induction of the respective
RNF8alleles resistant to the shRNA (Figure 5B). Significantly,
while reintroduction of WT RNF8 restored 53BP1 focus for-
mation in IR-treated cells (Figure 5C, left), and accumulation
of conjugated ubiquitin in laser-generated DSB tracks
(Figure 5C, right), both the *FHA (active but unable to accu-
mulate at DSBs) and *RING (able to accumulate at DSBs but
inactive) mutants failed to do so (Figure 5C). Thus, both
MDC1-mediated accumulationofRNF8and itsRING-finger-
associated ubiquitin ligase activity are required for local
increase of DSB-associated ubiquitylations and the ensuing
accumulation of repair proteins in this compartment.
DSB-Associated RNF8 Promotes Ubiquitylation
of H2A
To elucidate the identity of the RNF8-mediated ubiquitin
conjugates at DSBs, we applied fluorescence recovery
after photobleaching (FRAP) (Lukas et al., 2004a; Bek-
ker-Jensen et al., 2005) and analyzed the intranuclear
dynamics of the WT and the catalytically-inactive (*RING)
versions of RNF8. While the mobility of both proteins in
the undamaged nucleoplasm was similar, their dynamics
at the microlaser-generated DSBs were markedly differ-
ent (Figure 6A). The mean residence time at DSBs of the
inactive RNF8 extended up to 14.7 ± 0.1 s, which was
more than three times longer than the WT protein (4.3 ±
0.1 s). Together with the biochemical analysis showing
significant enrichment of the RING-deficient RNF8 in chro-
matin fractions (Figure S9A), these data suggest that the
RNF8 substrate (from which the catalytically inactive
Figure 5. Local Concentration and Catalytic Activity of RNF8 Determine Retention of 53BP1 at the DSB-Flanking Chromatin
(A) U-2-OS/shRNF8 cells were induced or not with Dox for 48 hr, exposed to laser microirradiation, and 1 hr later coimmunostained with antibodies to
RAP80 and g-H2AX.
(B) U-2-OS/shRNF8 cells engineered to induce various alleles of FLAG-tagged, shRNA-resistant RNF8 were incubated or not with Dox, and the
expression of the induced RNF8 proteins was monitored by immunoblotting with anti-FLAG antibody.
(C) U-2-OS/shRNF8/FLAG-RNF8 cells from (B) were induced with doxycycline (Dox) for 48 hr and exposed to IR (4 Gy) (left) or microirradiated by the
laser (right). After 1 hr, the cells were coimmunostained with antibodies to g-H2AX and 53BP1 (left) or conjugated ubiquitin (FK2) (right). Scale bars,
10 mm.
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RNF8 may not readily dissociate) could be a constitutive
component of chromatin.
To test this hypothesis, we examinedwhetherRNF8 func-
tionally interacts with H2A, a core histone that undergoes
increased monoubiquitylation in response to UV-induced
DNA damage (Bergink et al., 2006). Indeed, at least five
independent pieces of evidence indicated a functional link
between RNF8 and H2A. First, RNF8 physically interacted
with H2A, and this interaction was much stronger after
disrupting the RING domain of RNF8 (Figure 6B). Second,
using an optimized assay to monitor histone ubiquitylation
(Wang et al., 2006) we could detect an increase in the
FLAG-H2A ubiquitylation of cells exposed to IR, and this
increase was reduced after knocking down endogenous
RNF8 (Figure 6C). Third, consistent with the requirement
of MDC1 for RNF8 recruitment, MDC1 knockdown abro-
gated the IR-induced ubiquitylation of FLAG-H2A (Fig-
ure S9B). Fourth, the recombinant RNF8, but not the
RING-deficient mutant, catalyzed ubiquitylation of H2A in
an in vitro ubiquitylation assay (Figure 6D). Finally, an anti-
body specific to ubiquitylated H2A detected a clear accu-
mulation of ubiquitin species at the microlaser-generated
DSB sites, and this H2A-ubiquitin accumulation was
inhibited by RNF8 knockdown (Figure 6E). Thus, H2A
emerged as a strong candidate substrate of the DSB-asso-
ciated RNF8 ubiquitin ligase. Interestingly, we noticed that
depletion of RNF8 partially decreased also the overall H2A
ubiquitylation even in nonirradiated cells (Figure 6C).
Although we cannot exclude a damage-unrelated function
of RNF8, this observation may also reflect spontaneous
DNA breakage associated with replication errors.
To test whether RNF8 targets other histones, we
extended the in vitro ubiquitylation assay and tested the abil-
ity of RNF8 to catalyze ubiquitylation of H2A, H2AX, H2B,
and H3. While H2A and its structurally related variant
H2AX were robustly ubiquitylated under these conditions,
H2B and H3 were modified much less efficiently (Fig-
ure S9C). Interestingly, the ubiquitylation pattern of H2AX
resembled that of H2A, and in both cases, WT RNF8 (but
not theRING-deficientmutant) catalyzed attachment ofmul-
tiple ubiquitin moieties (Figures 6D and S9C). Consistently,
the oligo-ubiquitylation of FLAG-tagged H2A (Figure 6C)
and to a lesser extent H2AX (Figure S9D) was also observed
in cells, and themain ubiquitin specieswere induced by IR in
an RNF8-dependent manner. Finally, similar oligo-ubiquity-
lated (and IR-inducible) H2A species were also observed
on endogenous H2A immunopurified from native cell ex-
tracts by an antibody to ubiquitylated H2A (Figure S9E). To-
gether, these data suggest that RNF8 increases local ubiq-
uitylation of H2A (and to some extent also H2AX), and that
these histone modifications closely correlate with the transi-
tion of the DSB-flanking chromatin to a state permissive for
BRCA1 and 53BP1 accumulation.
RNF8 Facilitates Survival after a DSB-Generating
Insult
Finally, we tested the impact of RNF8 on DNA-damage
signaling and cell survival in an isogenic cell line capable
of conditional RNF8 knockdown. Reduction of RNF8
levels had little effect on cell-cycle progression in undam-
aged cells, indicating that the effect of RNF8 on BRCA1
and 53BP1 was not simply a consequence of a cell-cycle
arrest (Figure S7C). In addition, the IR-induced phosphor-
ylation of four independent ATM/ATR targets (SMC1, p53,
CHK2, and CHK1) appeared normal (Figure S7D). This is
consistent with our previous findings (Figures 3C and
4A) that RNF8, and the dynamic nuclear ubiquitylations,
neither affect accumulation of MDC1 and NBS1 at the
DSB sites (both events are known to facilitate ATM signal-
ing [Falck et al., 2005; Lou et al., 2006; You et al., 2005])
nor interfere with the DSB resection and formation of
the ssDNA compartments (Figure S7B), the structures
required for activation of the ATR-Chk1 pathway (Cortez
et al., 2001; Jazayeri et al., 2006). In agreement with these
results, we did not observe significant defects in the cell-
cycle checkpoints after RNF8 knockdown (our unpub-
lished observations). We then tested whether the same
degree of RNF8 downregulation would have any effect
on clonogenic survival after a DSB-generating insult.
When challenged with moderate doses of IR (2 Gy) the
transient knockdown of RNF8 significantly reduced the
fraction of surviving cells (Figure 6F). Together with
the lack of obvious defects in ATM/ATR-mediated phos-
phorylations (Figure S7D) and the strong impairment of
53BP1 and BRCA1 focus formation in the absence of
RNF8 (Figure 4A), these data suggest that the increased
radiation sensitivity of RNF8-deficient cells reflects the in-
ability to retain BRCA1 and 53BP1 (and possibly other ge-
nome surveillance factors) in the vicinity of the chromo-
somal lesions.
DISCUSSION
Our results suggest that RNF8 functions at the crossroads
between two main stages of the DSB-induced chromatin
response (Figure 7). While the first stage is competent to
support DSB signaling, it is not permissive to increase
local concentration of repair factors such as 53BP1 and
BRCA1. This is only achieved in the second step, and
the transition into this ‘‘mature’’ stage is critically depen-
dent on the RNF8 ubiquitin ligase. The key question posed
by this model is how does RNF8 promote local accumula-
tion of proteins as diverse as 53BP1 and BRCA1? Two
major scenarios come tomind. The first (‘‘direct’’) scenario
assumes that the RNF8-mediated histone ubiquitylation
recruits the molecular machinery that tethers both pro-
teins to the DSB-modified chromatin. According to the
second (‘‘indirect’’) scenario, RNF8 promotes a higher-
order chromatin restructuring to facilitate local exposure
of constitutive chromatin marks that in turn increase local
affinity for 53BP1 and BRCA1. Below we discuss the fact
that both models are plausible and not necessarily mutu-
ally exclusive.
The direct scenario is supported by the four recent stud-
ies showing that the ubiquitin-binding protein RAP80 is
required to target BRCA1 to DSBs (Kim et al., 2007;
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Figure 6. DSBs Trigger RNF8-Dependent Ubiquitylation of H2A
(A) U-2-OS cell lines stably expressing the indicated GFP-tagged RNF8 constructs were exposed to laser microirradiation. After 1 hr, the GFP-
associated fluorescence was bleached in small rectangular regions (2 3 2 mm) placed either to the undamaged nucleoplasm or over the laser-
generated DSB tracks, and the fluorescence recovery in these regions was determined by repetitive image acquisition. The recovery curves were
derived from 10 independent cells for each condition.
(B) HEK293T cells were transfected with indicated FLAG-RNF8 constructs. Cells were lysed in EBCbuffer containing 500mMNaCl, and extracts were
subjected to immunoprecipitation with anti-FLAG agarose beads. Bound complexes were analyzed by immunoblotting with the indicated antibodies.
(C) U-2-OS/shRNF8 cells were left untreated or induced by addition of Dox. Twenty-four hours later, cells were transfected with indicated constructs
for an additional 24 hr and mock-treated or exposed to IR (20 Gy) for 1 hr. Total cell extracts were prepared by lysing cells in denaturing buffer and
subjected to immunoprecipitation with anti-FLAG agarose beads under denaturing conditions. Bound complexes were analyzed by immunoblotting.
(D) The capability of purifiedGST-RNF8 proteins to ubiquitylate HistoneH2A in vitro was analyzed as described in Experimental Procedures. Reaction
mixtures were resolved by SDS-PAGE and analyzed by immunoblotting.
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Sobhian et al., 2007; Wang et al., 2007; Yan et al., 2007).
Although identification of the ubiquitin-dependent step in
BRCA1 focus formation was important, none of these
studies identified the enzymatic machinery that would lo-
cally ubiquitylate the DSB compartments and allow their
recognition by RAP80. Our studymay provide this missing
link and allow us to describe the BRCA1 retention at the
DSB-modified chromatin in a more complete fashion
(Figure 7). Thus, the BRCA1 ‘‘assembly line’’ starts with
phosphorylation of H2AX, followed by formation of the
g-H2AX-MDC1 complex, increased local concentration
of ATM, phosphorylation of MDC1, and its recognition
by the FHA domain of RNF8. The resulting recruitment of
RNF8 increases local ubiquitylation of histones such as
H2A and H2AX, which may provide a direct recognition
signal for the ubiquitin-interaction domains of RAP80.
The entire pathway is then completed by ABRA1, a medi-
ator protein that can simultaneously bind to RAP80 and
the BRCT domains of BRCA1 (Wang et al., 2007).
In contrast to BRCA1, the mechanism of the DSB-
induced accumulation of 53BP1 is less clear. While our
results clearly implicate a ubiquitin-dependent step in
this process, the link between the RNF8-mediated H2A/
H2AX ubiquitylation and the Tudor-dependent binding of
53BP1 to methylated H3 or H4 remains elusive. One pos-
sibility is that RNF8, and the DSB-associated histone
ubiquitylations, may also have an indirect impact on mat-
uration of the DSB-flanking chromatin (Figure 7). In sup-
port for this indirect scenario, we noticed that genetic
ablation of the TRRAP-TIP60 histone acetyltransferase
(HAT) generated a phenotype that was remarkably similar
to what we have observed after RNF8 knockdown (Murr
et al., 2006; this study). In each case, assembly of
MDC1 at the DSB sites was normal but accumulation of
both 53BP1 and BRCA1 was impaired. Because histone
hyperacetylation is often coupled to the less compacted
chromatin (Kouzarides, 2007), it is possible that local
relaxation of the DSB-flanking regions contributes to the
full-scale retention of BRCA1 and 53BP1 in this compart-
ment, and that both histone ubiquitylation and acetylation
contribute to this process. Our findings that RNF8 accu-
mulates at DSBs extremely rapidly suggest that RNF8
may operate upstream of the TRRAP-TIP60 complex,
possibly by stimulating its access to the DSB-flanking
chromatin and/or by enhancing its HAT activity. Such an
indirect scenario is attractive not only because it suggests
a way to unmask cryptic methyl residues required for
53BP1 recruitment but also because it provides an oppor-
tunity to amplify the RAP80-mediated signal to locally
concentrate BRCA1. It is important to realize that H2A
and H2AX are also ubiquitylated in unstressed cells. How-
ever, it is also possible that in the context of intact inter-
phase chromatin, the bulk of these ubiquitin conjugates
may not be readily accessible to interact with ubiquitin-
binding factors. We can imagine that even a modest
increase of RNF8-mediated histone ubiquitylation (per-
haps in conjunction with locally enhanced HAT activity)
may alter chromatin configuration to an extent that would
also expose the pre-existing histone-associated ubiquityl
groups and thereby nucleate a more efficient ‘‘affinity
trap’’ for RAP80 and indeed the entire machinery that con-
centrates BRCA1 in the vicinity of unrepaired DNA breaks.
A recent study reported H2A ubiquitylation after ultravi-
olet (UV)-induced DNA damage (Bergink et al., 2006).
(E) U-2-OS/shRNF8 cells were induced or not with Dox for 48 hr, exposed to laser microirradiation, and 1 hr later coimmunostained with antibodies to
ubiquitylated H2A and g-H2AX.
(F) U-2-OS/shRNF8 cells were induced or not with Dox for 24 hr, split by a limited dilution (+ Dox), and after an additional 24 hr exposed to the
indicated doses of IR. Subsequently, the cells were incubated for an additional 14 days and stained with crystal violet. Colonies containing more
than 50 cells were counted. The experiment was carried out in triplicates. Error bars represent standard error; scale bars, 10 mm.
Figure 7. A Schematic Model of the Two-Step Chromatin Re-
sponse to DSBs and the Involvement of RNF8 in This Process
RNF8 recruitment to the DSB sites is triggered by the ATM-mediated
phosphorylation of MDC1 (Step I). Once recruited, RNF8 catalyzes
ubiquitylation of H2A. At this point, the DSB-flanking chromatin be-
comes competent to recruit and accumulate 53BP1 and BRCA1
(Step II). Asterisk indicates that H2AX, a structural variant of H2A,
can also be targeted by RNF8 and may contribute to the transition
between the initial and advanced stages of the DSB-induced chroma-
tin response. See Discussion for details.
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Although the UV-induced H2A ubiquitylation required ATR
(conceptually similar to the ATM-dependent RNF8 regula-
tion described here), some aspects of its regulation dif-
fered from the DSB response. Thus, the UV-induced
H2A ubiquitylation was mediated by RNF2 (also known
as RING1B), a canonical ubiquitin ligase required for
H2A ubiquitylation associated with transcriptional silenc-
ing (de Napoles et al., 2004;Wang et al., 2004). In addition,
it occurred relatively late after UV exposure and did not
require H2AX (Bergink et al., 2006). Despite these differ-
ences (likely reflecting the fundamentally distinct repair
machineries involved in DSBs and UV lesions), H2A ubiq-
uitylation emerges as a general histone modification in-
duced byDNA damage.While the rapid H2A ubiquitylation
after DSBs serves to retain proteins engaged with various
aspects of DSB repair, the delayed H2A ubiquitylation
after UV may facilitate events that have high demands
on a permissive chromatin configuration and are specific
for UV-generated lesions such as repair of actively tran-
scribed DNA strands.
Our findings, and the accompanying paper by Chen and
colleagues, who reached similar conclusions (Huen et al.,
2007 [this issue of Cell]), complement the emerging role of
regulatory ubiquitylations in diverse aspects of the DNA-
damage response by identifying an RNF8-dependent
step during thematuration of the DSB-induced chromatin.
We propose that the key purpose of the RNF8-controlled
transition to the advanced stages of the DSB-induced
chromatin response is to concentrate repair factors in
the vicinity of DNA breaks to the threshold required for
timely and accurate restoration of genome integrity.
Both BRCA1 and 53BP1 are established tumor suppres-
sors (Boulton, 2006; Morales et al., 2006; Ward et al.,
2005). Identification of RNF8 as an upstream regulator of
BRCA1 opens up the possibility that RNF8 might be tar-
geted by mutations in a subset of breast and ovarian can-
cers, where the sequence of BRCA1 remains unaffected.
EXPERIMENTAL PROCEDURES
Plasmids and RNA Interference
A cDNA for human RNF8 (a gift from Yukio Okano) was inserted by
PCR into pEGFP-C1 (Clontech) and pFLAG-CMV2 (Sigma), respec-
tively. The *FHA (R42A) and *RING (C403S) mutations were generated
using the QuikChange Site-Directed Mutagenesis Kit (Stratagene). An
expression plasmid for HA-MDC1 (1–1100) was generated by insertion
of a corresponding MDC1 PCR fragment into pcDNA4/TO (Invitrogen),
containing two N-terminal HA-tags. The FLAG-H2A plasmid was a
gift from Moshe Oren. Plasmid transfections were performed using
FuGene 6 (Roche). siRNA oligonucleotides (Dharmacon) were synthe-
sized to the following sequences (sense strand): RNF8-1 (50-GGACAA
UUAUGGACAACAA-30), RNF8-2 (50-UGCGGAGUAUGAAUAUGAA-30),
MDC1 (Goldberg et al., 2003), and GL2 (control) (Mailand et al., 2006).
All siRNA transfections were performed with 100 nM siRNA duplexes
using Lipofectamine RNAiMAX (Invitrogen). A vector for inducible
expression of RNF8-specific shRNA was generated by insertion of
50-phosphorylated oligos containing the RNF8 target sequence (50-AC
ATGAAGCCGTTATGAAT-30) into pSUPERIOR.puro (Oligoengine). To
generate shRNA-insensitive FLAG-RNF8 constructs, the underlined
silent mutations (ACATGAGGCGGTTATGAAT) were introduced into
the shRNF8 target sequence in the RNF8 coding region.
Cell Culture
Human U-2-OS osteosarcoma cells and 293T human embryonic
kidney cells were grown in DMEM containing 10% fetal bovine serum
(GIBCO). Where indicated, the culture medium was supplied by the
proteasome inhibitor MG132 (Calbiochem: 5 mM). U-2-OS cell lines
stably expressing GFP-RNF8, FLAG-RNF8, or shRNF8 constructs in
a Dox-inducible fashion were generated as described (Mailand et al.,
2006). The U-2-OS cell lines stably expressing MDC1-shRNA, GFP-
MDC1, GFP-53BP1, GFP-ATR, and NBS1-RFP were described (Bek-
ker-Jensen et al., 2006; Jazayeri et al., 2006). U-2-OS cells stably
expressing GFP-BRCA1 together with its heterodimerizing partner
FLAG-BARD1 were generated using standard procedures (Bekker-
Jensen et al., 2005; Lukas et al., 2004a) and are characterized in
Figure S1. IR was delivered by the X-Ray generator (Pantak HF160,
150 kV, 15 mA, dose rate 2.18 Gy/min). Clonogenic survival assay is
specified in the figure legends (Figure 7F).
Immunochemical Methods
Immunochemical assays were described (Bekker-Jensen et al., 2005,
2006; Lukas et al., 2004a; Mailand et al., 2006). Rabbit antiserum to
RNF8 was raised against a peptide spanning residues 203–217 of
human RNF8. Other antibodies included mouse and rabbit antibodies
to HA-tag (sc-7392 and sc-805), rabbit polyclonal antibodies to GFP
(sc-8334, Santa Cruz), histone H2A (Ab-18255, Abcam), RAP80
(BL2839, Bethyl Laboratories), phospho-SQ/TQ (2851, Cell Signaling),
and mouse monoclonal antibodies to conjugated ubiquitin (FK2; Bio-
mol, PW 8810) and to ubiquitylated H2A (05-678, Upstate). The spec-
ificity of the latter antibody for ubiquitylated H2A was demonstrated
earlier (Baarends et al., 2005). Antibodies to FLAG, MCM6, g-H2AX,
Cyclin B1, MDC1, NBS1, 53BP1, and BRCA1 were described (Bek-
ker-Jensen et al., 2006; Mailand et al., 2006).
Microscopy and Laser Microirradiation
Confocal images were acquired on LSM-510 (Carl Zeiss Microimaging
Inc.) mounted on Zeiss-Axiovert 100M equipped with Plan-Neofluar
403/1.3 oil immersion objective. Laser microirradiation to generate
local DSBs and conditions for timelapse microscopy were described
(Bekker-Jensen et al., 2005, 2006; Lukas et al., 2003, 2004a). FRAP
assays including themathematical analysis of the data were described
previously (Lukas et al., 2004a).
Histone Ubiquitylation Assays
Histone ubiquitylation assays were performed essentially as described
(Wang et al., 2006). Cells were cotransfected with FLAG-tagged
histones and Myc-tagged ubiquitin and dissolved by sonication in de-
naturing buffer (20 mM Tris, pH 7.5; 50 mM NaCl, 0.5% NP-40; 0.5%
Deoxycholate; 0.5% SDS; 1 mM EDTA) containing protease inhibitors.
Cell extracts were subjected to immunoprecipitation with anti-FLAG
M2 agarose beads (Sigma) under denaturing conditions and purified.
Bound material was analyzed by immunoblotting. For in vitro ubiquity-
lation assays, 1 mg of histones H2A, H2B, H3 (New England Biolabs), or
H2AX (Upstate) was incubated in 30 ml reaction mixture containing
50 mM Tris, pH 7.5; 5 mM MgCl2; 2 mM NaF; 2 mM ATP; 10 mM Oka-
daic acid; 1 mMDTT; 0.1 mg E1; 0.2 mg UbcH5c; and 1 mg HA-ubiquitin
(all from Boston Biochem). Two hundred nanograms of bacterially pu-
rified, full-length GST-RNF8was added, and reactions were incubated
for 1 hr at 37C, stopped by the addition of Laemmli Sample Buffer,
and resolved by SDS-PAGE. Ubiquitylated histones were detected
by immunoblotting as specified in the figure legends.
Supplemental Data
Supplemental Data include nine figures and can be found with this
article online at http://www.cell.com/cgi/content/full/131/5/887/DC1/.
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 Introduction 
 In response to genotoxic stress, eukaryotic cells elicit DNA 
damage checkpoint responses, which delay cell cycle progres-
sion and stimulate DNA repair to restore genomic integrity 
( Zhou and Elledge, 2000 ;  Bartek and Lukas, 2007 ). DNA dam-
age triggers rapid degradation of the Cdk-activating phospha-
tase, Cdc25A, by the SCF   TrCP ubiquitin ligase to arrest the cell 
cycle in a reversible fashion ( Mailand et al., 2000 ;  Busino et al., 
2003 ). This process requires priming phosphorylation of Cdc25A 
by the checkpoint kinase Chk1, which is itself activated by 
phosphorylation by the upstream kinase ataxia telangiectasia 
and Rad3-related (ATR). Effi cient ATR-mediated phosphoryla-
tion of Chk1 occurs only in the presence of the checkpoint me-
diator Claspin, a key determinant for Chk1 activation ( Kumagai 
and Dunphy, 2000 ). Upon entry into mitosis and during recov-
ery from DNA damage – induced cell cycle arrest, Claspin under-
goes proteasomal degradation, and such control of Claspin 
levels plays a pivotal role in restraining Chk1 activity under 
these conditions ( Mailand et al., 2006 ;  Mamely et al., 2006 ; 
 Peschiaroli et al., 2006 ). Like in the case of Cdc25A, the de-
struction of Claspin is also mediated by SCF   TrCP ; hence, this 
complex plays a key role in initiating as well as terminating 
DNA damage checkpoints. These fi ndings have helped to estab-
lish regulated ubiquitylation as a major signaling mechanism in 
the DNA damage response. 
 The removal of ubiquitin conjugates from target proteins 
by deubiquitylating enzymes (DUBs) has emerged as an impor-
tant regulatory mechanism in a range of cellular processes. An 
estimated 79 functional DUBs are encoded by the human ge-
nome, but as yet, only few of these have been assigned func-
tions or substrates ( Nijman et al., 2005b ). Available evidence 
suggests that the specifi city and regulatory potential of DUBs 
may be comparable to that of E3 ubiquitin ligases, underscoring 
the dynamic and reversible nature of protein ubiquitylation. 
Several DUBs have been found to function in the DNA damage 
response, including ubiquitin-specifi c protease 1 (USP1), USP7, 
and USP28 ( Nijman et al., 2005a ;  Huang et al., 2006 ;  Zhang 
et al., 2006 ). For instance, USP7 (also known as HAUSP) is a 
DUB for Mdm2 ( Li et al., 2004 ), a ubiquitin ligase for p53, and 
is thus an important factor in the control of p53 abundance dur-
ing the cell cycle. 
Claspin is an adaptor protein that facilitates the ataxia telangiectasia and Rad3-related (ATR)-mediated phosphorylation and activation of 
Chk1, a key effector kinase in the DNA damage re-
sponse. Efﬁ cient termination of Chk1 signaling in mitosis 
and during checkpoint recovery requires SCF   TrCP -
 dependent destruction of Claspin. Here, we identify the 
deubiquitylating enzyme ubiquitin-speciﬁ c protease 7 
(USP7) as a novel reg ulator of Claspin stability. Claspin 
and USP7 interact in vivo, and USP7 is required to 
maintain steady-state levels of Claspin. Furthermore, 
USP7-mediated deubiquitylation markedly prolongs the 
half-life of Claspin, which in turn increases the magnitude 
and duration of Chk1 phosphorylation in response 
to genotoxic stress. Finally, we ﬁ nd that in addition to 
the M phase – speciﬁ c, SCF   TrCP -mediated degradation, 
Claspin is destabilized by the anaphase-promoting 
complex (APC) and thus remains unstable in G1. Impor-
tantly, we demonstrate that USP7 speciﬁ cally opposes 
the SCF   TrCP - but not APC Cdh1 -mediated degradation of 
Claspin. Thus, Claspin turnover is controlled by multiple 
ubiquitylation and deubiquitylation activities, which to-
gether provide a ﬂ exible means to regulate the ATR –
 Chk1 pathway.
 USP7 counteracts SCF   TrCP - but not APC Cdh1 -mediated 
proteolysis of Claspin 
 Helene  Faustrup ,  Simon  Bekker-Jensen ,  Jiri  Bartek ,  Jiri  Lukas , and  Niels  Mailand 
 Institute of Cancer Biology and Centre for Genotoxic Stress Research, Danish Cancer Society, DK-2100 Copenhagen, Denmark 
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also required for Chk1 activation in response to genotoxic 
insults, was not affected by knockdown of USP7 or other DUBs 
( Fig. 1 A ). A mixture of three independent oligonucleotides 
was used to effi ciently knock down USP7 expression, and the 
effect of USP7 depletion on Claspin levels could be reproduced 
with individual siRNAs to USP7 (Fig. S1 A, available at http://
www.jcb.org/cgi/content/full/jcb.200807137/DC1). To clarify 
whether Claspin is a direct target of USP7, we tested whether 
the two proteins copurify in immunoprecipitation (IP) experi-
ments. Indeed, USP7 and Claspin readily interacted under con-
ditions where both proteins were overexpressed ( Fig. 1 B ), and 
we could also detect association between the endogenous pro-
teins ( Fig. 1 C ). In contrast, we did not observe binding of 
Claspin to several other DUBs (unpublished data), underscor-
ing the specifi city of the Claspin – USP7 interaction. To further 
probe the relationship between USP7 and Claspin, we assessed 
the Claspin-binding capability of wild-type (WT) or catalyti-
cally inactive (CI) USP7. In such experiments, USP7 CI inter-
acted more strongly with endogenous Claspin than did WT 
USP7 ( Fig. 1 D ), which is consistent with a substrate-trapping 
mechanism in which an inability of inactive USP7 to deubiqui-
tylate Claspin would manifest as a prolonged binding and thus 
a tighter interaction. These observations suggest that Claspin is 
a novel substrate for USP7. 
 Interestingly, depletion of USP7 also led to a signifi cant 
down-regulation of total Chk1 levels ( Fig. 1 A ), but we failed to 
produce credible evidence that Chk1 is a direct target for USP7. 
In particular, whereas Claspin avidly interacted with USP7, the 
amount of Chk1 coimmunoprecipitated with ectopic USP7 did not 
signifi cantly exceed that observed in the control cells ( Fig. 1 D ). In 
addition, knockdown of Claspin or Chk1 negatively affected the 
expression level of the other protein (Fig. S1 C), which suggests 
that Claspin and Chk1 may promote the stability of each other, 
in agreement with previous fi ndings ( Yang et al., 2008 ). Thus, it 
seems likely that the effects on Chk1 levels observed in response 
to up- or down-regulation of USP7 may be indirectly mediated 
through its impact on Claspin. 
 USP7 deubiquitylates and stabilizes Claspin 
 To corroborate the emerging link between USP7 and Claspin, 
we generated cell lines capable of conditionally expressing WT 
or CI mutant forms of Myc-tagged USP7. Induction of USP7 in 
these cell lines resulted in homogenous nuclear expression of 
the transgenes in virtually all cells, but had little impact on cell 
cycle distribution (Fig. S2, available at http://www.jcb.org/cgi/
content/full/jcb.200807137/DC1; and not depicted). Using these 
cell lines, we asked whether overexpression of USP7 would 
have a stabilizing effect on endogenous Claspin. Expression of 
USP7 WT clearly resulted in an elevation of Claspin levels, 
whereas no such effect could be seen in cells induced to express 
USP7 CI ( Fig. 2 A ). Only a slight increase in Chk1 levels was 
evident under these conditions, which further supports the no-
tion that Claspin rather than Chk1 is a target of USP7. As a con-
trol for the functionality of ectopic USP7 in the cell lines, we 
analyzed its impact on Mdm2, a known target for USP7. Indeed, 
Mdm2 abundance was strongly elevated in a manner dependent 
on the catalytic activity of USP7 but independent of cell cycle 
 In this report, we show that the control of Claspin stability 
is more complex than previously anticipated, involving both 
ubiquitylation and deubiquitylation to allow cells to fi nely 
gauge the levels of Claspin. We identify USP7 as a major DUB 
for Claspin, with a consequent impact on Chk1 phosphorylation 
and checkpoint recovery. We also demonstrate that Claspin is 
degraded by the anaphase-promoting complex (APC) in the G1 
phase, and that USP7 specifi cally counteracts SCF   TRCP - but not 
APC Cdh1 -mediated ubiquitylation of Claspin. 
 Results and discussion 
 Claspin interacts with USP7 
 To explore the dynamic control of Claspin stability, we investi-
gated whether Claspin is regulated by deubiquitylation activities. 
Focusing on a selected set of DUBs, which have previously been 
implicated in the DNA damage response, we monitored the re-
sponse of Claspin levels to siRNA-mediated down-regulation of 
these DUBs. Consistent with published results ( Zhang et al., 
2006 ), we observed a partial reduction in Claspin level after 
knocking down USP28 ( Fig. 1 A ). Strikingly, however, we con-
sistently detected a much more prominent decrease of Claspin 
expression after depletion of USP7, which suggests that USP7 
might protect Claspin from ubiquitylation-dependent degrada-
tion ( Fig. 1 A ). However, the abundance of TopBP1, which is 
 Figure 1.  Claspin interacts with USP7. (A) U2OS cells were transfected 
with indicated siRNAs for 72 h and analyzed by IB with the indicated 
antibodies. The functionality of the USP1 siRNA has been demonstrated 
previously ( Huang et al., 2006 ). (B) Lysates of 293T cells transfected with 
indicated plasmids for 24 h were subjected to Myc IP followed by IB. (C) Ly-
sates of 293T cells were subjected to IP with USP7 antibody or preimmune 
rabbit serum (IgG) followed by IB. (D) 293T cells were transfected with WT 
or CI forms of Myc-USP7, and processed as in B. The extra band in the 
USP7 CI lane corresponds to ubiquitylated USP7 (unpublished data). 
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G1 ( Mailand et al., 2006 ). Degradation of Claspin at the onset 
of mitosis is driven by its ubiquitylation by SCF   TrCP , and we 
therefore asked whether overexpression of USP7 could counter-
act this process. To this end, we assessed the impact of ectopic 
USP7 on the levels of Claspin in mitotic cells. In uninduced 
cells, Claspin was indeed expressed at much lower levels in 
mitotic cells than in exponentially growing cells ( Fig. 2 D ). 
However, as would be expected if USP7 was able to reverse 
SCF   TrCP -mediated ubiquitylation of Claspin, induction of USP7 
WT fully restored Claspin levels to those seen in asynchronous 
cells ( Fig. 2 D ). Again, this propensity of USP7 was dependent 
on the catalytic activity of USP7, as the abundance of Claspin 
remained low in mitotic cells expressing USP7 CI ( Fig. 2 D ). 
Because extracts from mitotic cells readily support ubiquity-
lation of Claspin in a   TrCP-dependent fashion ( Mailand et al., 
2006 ), we used such an approach to test whether USP7 directly 
stage ( Fig. 2 A and Fig. S2 C). To clarify further whether Claspin 
is stabilized by USP7-dependent deubiquitylation, we assessed 
the half-life of Claspin in cells expressing ectopic USP7 by add-
ing cycloheximide to block protein synthesis. Overexpression 
of USP7 WT brought about a robust, three- to fourfold increase 
in the stability of Claspin as compared with uninduced cells, in 
which the half-life of Claspin was very short (  1 h,  Fig. 2 B ). 
In contrast, little if any effect on Claspin stability was evident in 
cells expressing USP7 CI ( Fig. 2 C ), which supports the idea 
that Claspin is deubiquitylated by USP7. 
 USP7 reverses SCF   TrCP -dependent 
ubiquitylation of Claspin 
 We have previously shown that the levels of Claspin oscillate in 
a cell cycle – dependent manner, being high in S and G2 phases 
and declining sharply upon entry into mitosis and throughout 
 Figure 2.  USP7 deubiquitylates and sta-
bilizes Claspin. (A) U2OS/Myc-USP7 cell 
lines were induced with doxycycline (DOX), 
harvested at the indicated times, and pro-
cessed for IB with the indicated antibodies. 
(B) U2OS/Myc-USP7 WT cells were induced 
or not induced with DOX for 30 h, after which 
cycloheximide (CHX) was added to the cultures 
for the indicated times. The half-life of Claspin 
was estimated by IB of total cell extracts. 
(C) U2OS/Myc-USP7 CI cells were treated as 
in B. (D) U2OS/Myc-USP7 WT or CI cells were 
induced or not induced for 18 h with DOX, 
and left untreated (Exp) or incubated with no-
codazole for an additional 12 h to synchro-
nize cells in mitosis (M). The cell extracts were 
then analyzed by IB. Mobility-shifted Wee1 
served as a marker for mitotically synchro-
nized cells. (E) [ 35 S]-labeled Claspin (amino 
acids 1 – 380) was incubated in ubiquitylation 
reaction mix, then supplemented with extracts 
of exponentially growing or mitotic U2OS cells 
and in vitro – translated   TrCP1. Where indi-
cated, bacterially puriﬁ ed GST-USP7 WT was 
added to the reaction. Claspin ubiquitylation 
was visualized by autoradiography. Numbers 
to the right of the gel blots indicate molecular 
mass standards in kD. (F) U2OS/Myc-USP7 
cell lines were transfected with indicated con-
structs for 24 h, and lysates were processed 
for IP with FLAG antibody and IB. 
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fact that priming phosphorylation of Claspin by the Plk1 ki-
nase is required for its SCF   TrCP -mediated destruction ( Mailand 
et al., 2006 ;  Mamely et al., 2006 ;  Peschiaroli et al., 2006 ); the 
absence of Plk1 in G1, because of its destruction by APC Cdh1 
( Peters, 2006 ), thus necessitates a Plk1-independent mecha-
nism for the G1-specifi c degradation of Claspin. 
 As mentioned previously, the APC Cdh1 -mediated degrada-
tion of Claspin appeared insensitive to USP7 activity ( Fig. 3 A ), 
and to confi rm this, we tested the ability of APC Cdh1 to degrade 
Claspin in the presence of elevated levels of USP7. Unlike inacti-
vation of APC Cdh1 , expression of ectopic USP7 WT did not restore 
Claspin expression in G1 ( Fig. 3 E ), which indicates that the sta-
bilization of Claspin observed in these cells ( Fig. 2, A and B ) hap-
pens outside G1 phase. In addition, overexpressed USP7 failed to 
counteract Claspin degradation mediated by activated APC Cdh1 
( Fig. 3 F ). We conclude from these experiments that USP7 selec-
tively opposes the SCF   TrCP - but not APC Cdh1 -dependent degrada-
tion of Claspin, which suggests that the molecular nature of 
ubiquitin chains attached to Claspin by APC Cdh1 and SCF   TrCP 
differ in terms of their susceptibility or accessibility to USP7-
mediated deubiquitylation. 
 USP7 controls the timing of checkpoint-
induced Chk1 phosphorylation through 
regulation of Claspin stability 
 The role of USP7 in maintaining steady-state levels of Claspin 
suggested that modulation of USP7 activity might affect Chk1 
regulation during checkpoint responses. To test this, we fi rst 
assessed the ability of USP7-depleted cells to activate Chk1. 
Consistent with the quantitative loss of Claspin in such cells, 
knockdown of USP7 strongly impaired UV-dependent activa-
tion of Chk1, as judged from its phosphorylation on Ser317 
( Fig. 4 A ). As with Claspin levels, this effect was specifi c to 
USP7, as neither depletion of USP1 or USP28 signifi cantly 
compromised UV-induced Chk1 phosphorylation ( Fig. 4 A ). 
Hence, these data suggest that USP7 is required for Chk1 acti-
vation in response to DNA damage. 
 Destruction of Claspin by SCF   TrCP promotes the timely in-
activation of Chk1 during recovery from DNA damage – induced 
cell cycle arrest ( Mailand et al., 2006 ;  Mamely et al., 2006 ; 
Peschiaroli et al., 2006 ), and because USP7 protects Claspin 
from   TrCP-dependent degradation, we reasoned that the ac-
tivity of USP7 might be a contributing factor in timing the du-
ration of Chk1 phosphorylation during checkpoint responses. 
To this end, we analyzed the kinetics of Chk1 dephosphoryla-
tion, and thus checkpoint termination, in USP7 cell lines re-
leased from a replication block induced by hydroxyurea (HU). 
We consistently observed a strong delay in the ability of USP7 
WT-induced cells to degrade Claspin and inactivate Chk1 after 
release from the HU-induced arrest, relative to uninduced cells 
( Fig. 4 B ). This was accompanied by a slower rate of cell cycle 
progression upon HU removal, which might at least partially 
refl ect the delayed kinetics of Claspin degradation in these 
cells (Fig. S3, available at http://www.jcb.org/cgi/content/full/
jcb.200807137/DC1). The overall levels of Chk1 remained 
somewhat higher in cells induced to express USP7 WT, which 
is in agreement with the previously observed correlation 
deubiquitylates Claspin in vitro. As shown in  Fig. 2 E , the 
polyubiquitylation of Claspin observed in mitotic cells was in-
hibited when purifi ed GST-tagged USP7 WT was added to the 
reaction. In addition, induction of USP7 WT but not USP CI 
quantitatively suppressed the appearance of polyubiquitylated 
Claspin species in cells ( Fig. 2 F ), which indicates that USP7 
is a major Claspin-directed DUB. Together, these results dem-
onstrate that USP7 stabilizes Claspin by directly opposing its 
  TrCP-mediated ubiquitylation. Hence, the balance of ubiqui-
tylation and deubiquitylation activities allow for subtle control 
of steady-state levels of Claspin. 
 Claspin is degraded by the APC in G1 
 Although elevated levels of USP7 WT were able to maintain 
Claspin expression during mitosis, we noted that it was still 
degraded upon reentry into G1 phase ( Fig. 3 A ). This sug-
gested that once in G1, Claspin becomes susceptible to degra-
dation by a   TrCP-independent mechanism refractory to USP7 
activity. We reasoned that under these conditions, the destruc-
tion of Claspin might instead be driven by the APC, which 
promotes the degradation of numerous regulatory proteins in 
late mitosis and G1 ( Peters, 2006 ). To test this possibility, we 
coexpressed Claspin with Cdh1, the substrate-specifi c activa-
tor of the APC in G1, using the fi nding that elevated levels of 
Cdh1 are suffi cient to trigger APC activation irrespective of 
cell cycle stage ( Sorensen et al., 2000 ). In the presence of high 
levels of Cdh1, the expression of Claspin was strongly sup-
pressed ( Fig. 3 B ), which suggests that Claspin is indeed a 
target for APC-mediated degradation. To further probe this pro-
teolytic mechanism, we used an immunofl uorescence-based ap-
proach to monitor Claspin abundance in G1 cells. Although 
Claspin was detectable only at background levels in G1 phase 
(Cyclin B1 – negative) nuclei, treatment with a proteasome in-
hibitor (MG132) was suffi cient to restore Claspin expression 
to levels comparable with S and G2 phase cells ( Fig. 3 C ), 
demonstrating that Claspin is actively degraded by the protea-
some in G1. Next, we subjected cells to siRNA-mediated de-
pletion of   TrCP or Cdh1 to test whether the degradation of 
Claspin in G1 cells was predominantly mediated by SCF   TrCP 
or APC Cdh1 . Although Claspin did not accumulate in G1 cells 
in response to knockdown of   TrCP, its expression in G1 was 
effi ciently restored upon depletion of Cdh1 ( Fig. 3 C ), indicat-
ing that the degradation of Claspin in G1 phase is mediated by 
APC Cdh1 but not SCF   TrCP . In contrast, we had previously shown 
that the APC was unable to promote the degradation of Claspin 
in early mitosis ( Mailand et al., 2006 ). Thus, two distinct path-
ways operate to limit Claspin abundance during the cell cycle, 
in a manner much like Cdc25A, whose destruction is also con-
trolled by both SCF   TrCP and APC Cdh1 ( Donzelli et al., 2002 ). 
We speculate that the APC-mediated degradation of Claspin in 
G1 is an important means of suppressing inappropriate Chk1 
activation during this window of the cell cycle. Indeed, cells 
expressing elevated levels of Cdh1 were markedly impaired in 
their ability to activate Chk1 in response to UV, whereas the 
phosphorylation of other ATR targets remained virtually nor-
mal, as exemplifi ed by p53 ( Fig. 3 D ). The choice of APC as 
the machinery for Claspin ubiquitylation in G1 may refl ect the 
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 Figure 3.  Degradation of Claspin by APC Cdh1 in G1 is not opposed by USP7. (A) U2OS/Myc-USP7 WT cells were induced or not induced with DOX for 
18 h, and left untreated or synchronized in mitosis by nocodazole treatment for an additional 12 h. Mitotic cells were washed, plated in fresh medium, 
and collected at the indicated times after release. Lysates of these and asynchronous control cells (  ) were analyzed by IB. (B) U2OS/Myc-Cdh1 cells were 
induced by removal of tetracycline (Tet) for the indicated times and processed for IB. (C) U2OS cells were treated with MG132 for 4 h or transfected with 
  TrCP or Cdh1 siRNAs for 48 h. The cells were then ﬁ xed and immunostained with indicated antibodies. DNA was visualized by counterstaining with 
ToPro3. Arrows indicate G1 cells. Bars, 10  μ m. (D) U2OS/Myc-Cdh1 cells were induced or not induced by tetracycline withdrawal for 48 h, exposed to 
UV (20 J/m 2 ), and harvested 1 h later. Total cell extracts were processed for IB. (E) U2OS/Myc-USP7 WT cells were induced or not induced with DOX for 
48 h, and processed for immunoﬂ uorescence as in C. Arrows indicate G1 cells. Bars, 10  μ m. (F) U2OS cells were transfected with the indicated plasmids 
for 24 h and processed for IB. 
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tion of Chk1 but not other targets ( Liu et al., 2006 ). Most impor-
tantly, we identifi ed USP7 as a DUB opposing   TrCP-mediated 
ubiquitylation of Claspin, thus broadening the scope of USP7 
functions in the maintenance of genomic integrity. By protect-
ing Claspin from degradation, USP7 may directly impact the 
initiation as well as termination of Chk1-mediated signaling re-
sponses, and hence it will be important to address if and how the 
Claspin-directed activity of USP7 is itself regulated during 
checkpoint responses. A recent study also identifi ed Claspin as 
a novel APC target, and the DUB USP28 was found to oppose 
its APC-mediated ubiquitylation ( Bassermann et al., 2008 ). 
Hence, two distinct DUBs may be used to counteract Claspin 
ubiquitylation mediated by SCF   TrCP or APC Cdh1 , further high-
lighting the importance of tightly controlling its steady-state 
expression levels during the cell cycle. 
 Materials and methods 
 Plasmids and RNA interference 
 Plasmids expressing WT and CI (C223S) Myc-tagged USP7 (pcDNA3-
Myc-USP7) were gifts from R. Everett (MRC Virology Unit, University of 
Glasgow, Scotland, UK). The inserts were inserted into pcDNA4/TO (Invit-
rogen), allowing for doxycycline-inducible expression of Myc-USP7 WT 
and CI, and into pGEX-20T (GE Healthcare) for bacterial expression of 
GST-USP7 fusion proteins. Other plasmids used in this study included pIRES-
FLAG-Claspin, pCMV2-FLAG-Claspin (amino acids 1 – 448), pX-Myc-Claspin 
(amino acids 1 – 380), pX-Myc-Cdh1, and pX-Myc-  TrCP1, all of which 
have been described previously ( Mailand et al., 2006 ;  Sorensen et al., 
2000 ). Plasmid transfections were performed using FuGene6 (Roche). 
between Chk1 and Claspin levels. Consistent with the inability 
of USP7 CI to stabilize Claspin, cells expressing this mutant 
did not display any checkpoint recovery delay ( Fig. 4 C ). 
Hence, increased activity of USP7 interferes with the cellular 
ability to timely degrade Claspin and inactivate Chk1 upon 
checkpoint termination. 
 In addition to its role during checkpoint recovery,   TrCP-
dependent degradation of Claspin helps prevent inappropriate 
activation of Chk1 during mitosis ( Mailand et al., 2006 ;  Mamely 
et al., 2006 ). Consequently, mitotic cells depleted for   TrCP 
display partial Chk1 phosphorylation after exposure to geno-
toxic agents. Because USP7 stabilized Claspin in mitosis, we 
tested if mitotic cells overexpressing USP7 WT would allow 
Chk1 activation. Indeed, like   TrCP depletion, elevated levels 
of USP7 WT partially enabled phosphorylation of Chk1 upon 
exposure of mitotic cells to the DNA-damaging agent etoposide 
( Fig. 4 D ). These observations suggest that the ubiquitylation 
and deubiquitylation activities toward Claspin must be tightly 
coordinated to enforce Claspin degradation and thus Chk1 in-
activation in mitosis. 
 Collectively, our results uncover a dynamic and complex 
mode of controlling Claspin stability during the cell cycle and 
upon checkpoint-inducing stimuli involving both ubiquitylation 
and deubiquitylation activities. These fi ndings highlight the 
tuning of Claspin availability as a key regulatory event in path-
ways that govern Chk1 activation, and likely refl ect the fact that 
Claspin is specifi cally required for ATR-mediated phosphoryla-
 Figure 4.  USP7 controls the timing of Chk1 
phosphorylation through regulation of Claspin 
stability. (A) U2OS cells were transfected with 
indicated siRNAs for 72 h, then subsequently 
treated with UV (20 J/m 2 ) and harvested 
1 h later. Cells were then processed for IB. 
(B) U2OS/Myc-USP7 WT cells were induced 
or not induced with DOX for 12 h, and treated 
with HU for an additional 24 h. Cells were 
then released from the HU block, harvested 
at the indicated times, and processed for IB. 
(C) U2OS/Myc-USP7 CI cells were treated 
as in B. (D) U2OS/Myc-USP7 WT cells were 
induced or not induced with DOX for 24 h, 
and left untreated or synchronized in mitosis 
with nocodazole for an additional 12 h. Cells 
were then treated with etoposide for 2 h where 
indicated, and processed for IB. 
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A mixture of three different siRNAs were used to efﬁ ciently knock down 
USP7, as described previously ( Canning et al., 2004 ). Other siRNAs used 
in this study included USP1 (5  -GGCAAUACUUGCUAUCUUA-3  ;  Nijman 
et al., 2005a ) and USP28 (5  -CUGCAUUCACCUUAUCAUU-3  ). siRNA to 
Cdh1 and   TrCP have been described previously ( Mailand and Difﬂ ey, 
2005 ;  Mailand et al., 2006 ). All siRNA duplexes (purchased from Thermo 
Fischer Scientiﬁ c) were transfected at a ﬁ nal concentration of 100 nM using 
Lipofectamine RNAiMAX (Invitrogen). 
 Cell culture 
 Human U2OS osteosarcoma cells and HEK293T embryonic kidney cells 
were cultured in DME containing 10% fetal bovine serum. U2OS derivative 
cell lines expressing Myc-tagged USP7 WT or CI in a doxycycline-inducible 
fashion from pcDNA4/TO-Myc-USP7 vectors were generated and main-
tained as described previously ( Mailand et al., 2007 ). The U2OS/Myc-
Cdh1 cell line has been described previously ( Sorensen et al., 2000 ). Cells 
were synchronized in mitosis by shaking off rounded cells after treatment 
with 40 ng/ml nocodazole (Sigma-Aldrich) for 12 h. Other drugs used in 
this study included: 1  μ g/ml doxycycline (EMD), 2  μ g/ml tetracycline (EMD), 
2 mM HU (Sigma-Aldrich), 25  μ g/ml cycloheximide (Sigma-Aldrich), and 
etoposide (50  μ M for exponential and 100  μ M for mitotic cells; EMD). 
 Immunochemical methods and microscopy 
 Immunoblotting (IB), IP, and immunoﬂ uorescence were performed as de-
scribed previously ( Mailand et al., 2006 ). Antibodies used in this study in-
cluded mouse monoclonals to Strep-tag (IBA BioTAGnology) and Mdm2 
(sc-965; Santa Cruz Biotechnology, Inc.); rabbit polyclonals to USP7 
(BL851; Bethyl Laboratories, Inc.), Claspin (BL-73 [Bethyl Laboratories, Inc.] 
and Ab3720 [Abcam], used for IB and immunoﬂ uorescence, respectively), 
Wee1 (sc-325; Santa Cruz Biotechnology, Inc.), and USP28 (a gift 
from S.J. Elledge, Harvard Medical School, Boston, MA). Antibodies to 
FLAG, Myc, HA, cyclin B1, Chk1, Cdk7, Chk1 S317, SMC1, TopBP1, 
and MCM6 have been described previously ( Mailand et al., 2006 ). Acqui-
sition of confocal images was done essentially as described previously 
( Bekker-Jensen et al., 2006 ), using a confocal microscope (LSM510; Carl 
Zeiss, Inc.) ﬁ tted with a Plan-Neoﬂ uar 40 × NA 1.3 oil immersion objective 
lens (Carl Zeiss, Inc.). For dual-color imaging, secondary antibodies cou-
pled to Alexa Fluor dyes with excitation wavelengths of 488 and 568 nm 
were used. Image acquisition and basic image processing were performed 
with LSM software (Carl Zeiss, Inc.). 
 In vitro deubiquitylation assay 
 Claspin was ubiquitylated in vitro essentially as described previously 
( Mailand et al., 2006 ). In brief, in vitro – translated [ 35 S]Claspin (amino 
acids 1 – 380) was incubated with ubiquitylation reaction mix (40 mM 
Tris-HCl, pH 7.5, 5 mM MgCl 2 , 1 mM DTT, 10% glycerol, 1 mg/ml ubiqui-
tin, 10 mM phosphocreatine, 100  μ g/ml creatine phosphokinase, 0.5 mM 
ATP, 5  μ M MG132 [all from Sigma-Aldrich], 5  μ M human E1, and 2  μ M 
hUbcH5C [both from Boston Biochem]), then supplemented with 30  μ g of 
extract from exponentially growing or mitotic U2OS cells ( Mailand et al., 
2006 ) and unlabeled in vitro – translated   TrCP1. To assess the deubiquity-
lation activity of USP7 toward Claspin, 1  μ g of GST-USP7 WT puriﬁ ed from 
 Escherichia coli was included in the reaction. Reactions were incubated at 
30 ° C for 1 h, stopped by addition of Laemmli sample buffer, resolved by 
SDS-PAGE, and visualized by autoradiography. 
 Online supplemental material 
 Fig. S1 shows speciﬁ city and effects of USP7, Claspin, and Chk1 siR-
NAs. Fig. S2 shows characterization of the U2OS/Myc-USP7 inducible 
cell lines. Fig. S3 shows cell cycle proﬁ les of cells in the experiment in 
 Fig. 4 B at representative time points, determined by ﬂ ow cytometric 
analysis. Online supplemental material is available at http://www.jcb
.org/cgi/content/full/jcb.200807137/DC1. 
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RNF8 Ubiquitylates Histones at 
DNA Double-Strand Breaks and 
Promotes Assembly of Repair Proteins 
Niels Mailand, Simon Bekker-Jensen, Helene Faustrup, Fredrik Melander, Jiri Bartek, 
Claudia Lukas, and Jiri Lukas 
  
  
 
 
Figure S1. Characterization of new cell lines expressing GFP-tagged DSB 
regulators 
(A) Lysates from U-2-OS cells stably expressing the indicated forms of GFP-
RNF8 were analysed by immunoblotting with an anti-GFP antibody. SMC1 
served as a loading control. 
(B) Lysates from U-2-OS cells stably expressing GFP-RNF8 were analysed by 
immunoblotting with a rabbit antibody to RNF8. GFP-RNF8 was expressed at 
levels comparable to the endogenous proteins. MCM6 served as a loading 
control. 
(C) U-2-OS cells stably co-expressing GFP-BRCA1 and FLAG-BARD1 were 
analysed by immunoblotting with the indicated antibodies for migration and 
abundance of the integrated transgenes. SMC1 is a loading control. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Figure S2. Structural requirements of MDC1 for RNF8 interaction 
(A) The indicated fragments of HA-tagged human MDC1 were co-expressed with 
FLAG-RNF8 in 293T cells, and their interaction was measured by 
immunoprecipitation with anti-HA-antibody followed by immunoblotting with 
anti-FLAG antibody (the same conditions as in Fig. 2B). The drawing 
schematically illustrates the interaction capabilities of the respective MDC1 
fragments, and indicates the minimal region of MDC1 (red) that is necessary 
and sufficient to interact with RNF8.  
(B) A graphical alignment of conserved T-Q-X-F residues in MDC1 proteins from 
different mammalian species. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Figure S3. Disruption of the conserved T-Q-X-F domain in the MDC1 terminus 
does not affect NBS1 chromatin retention 
(A) U-2-OS/shMDC1 cells were co-transfected with GFP-RNF8 and the indicated 
versions of HA-MDC1 and assayed by immunoblotting with the indicated 
antibodies. MCM6 is a loading control.  
(B) U-2-OS cells were transfected with the wild-type (wt) HA-MDC1 or its 
variant where the threonines within all three conserved T-Q-X-F repeats were 
substituted by alanines (3A). Association between HA-MDC1 and endogenous 
NBS1 was analyzed by immunoprecipitation with anti-HA antibody followed 
by immunoblotting with NBS1 antibody.  
(C) U-2-OS/shMDC1 cells were transfected with the two forms of HA-tagged 
MDC1 as in (A), miroirradiated by the laser, and co-immunostained with 
antibodies to HA (to confirm productive expression of the MDC1 proteins and 
their ability to localize to DSB sites) and NBS1. WCE, whole cell extract. 
Scale bars, 10 µm. 
 
 
 
 
 
 
 
 
 
  
 
 
  
 
 
Figure S4. Endogenous BRCA1 and 53BP1 assemble at the DSB sites with a 
similar kinetics 
(A) U-2-OS cells were exposed to laser microirradiation, and at the indicated 
times fixed and co-immunostained with antibodies to endogenous BRCA1 and 
53BP1. The appearance and magnitude of both proteins in the microirradiated 
areas (and within the same cells) parallel each other. Scale bar, 10 µm. 
(B) U-2-OS cells were microirradaited as in A and co-immunostained with 
antibodies to RNF8 and MDC1. Recruitment of endogenous RNF8 was 
evident from the earliest time points (2 min after microirradiation) when 
accumulation Mdc1 became clearly detectable at the laser-generated DSB 
tracks. 
 (C) U-2-OS cells stably expressing physiological levels of GFP-RNF8 (see Fig. 
S1B) were exposed to IR (4 Gy) and at the indicated time-points 
immunostained with an antibody to γ-H2AX. During the entire time-course, 
the localization and intensity of GFP-RNF8 closely paralleled that of the γ-
H2AX-decorated chromatin. Scale bars, 10 µm. 
 
 
 
 
 
 
 
 
  
 
 
Figure S5. Accumulation of 53BP1 and BRCA1 at the DSB sites is independent 
of each other 
U-2-OS cells were treated with the indicated siRNA oligonuleotides for 72 h, 
subjected to laser microirradiation, and after additional 30 min fixed and co-
immunostained with the indicated antibodies. siRNA oligonucleotides to 
53BP1 (Bekker-Jensen et al., 2005), and GL2 (control; Mailand et al., 2006) 
were described. siRNA to BRCA1 was a SmartPool (MU-003461-01; 
Dharmacon) containing four oligonucleotides to the following sequences 
(sense strand): 5’-CAGCUACCCUUCCAUCAUAUU-3’; 5’-
GGGAUACCAUGCAACAUAAUU-3’; 5’-
GAAGGAGCUUUCAUCAUUCUU-3’; 5’-
CUAGAAAUCUGUUGCUAUGUU-3’. Scale bars, 10 µm.  
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
  
 
 
Figure S6. Inhibition of the 26S proteasome impairs regulatory ubiquitylations 
in the cell nucleus and inhibits 53BP1 retention in the DSB compartment 
(A) U-2-OS cells stably expressing GFP-tagged ubiquitin were treated with the 
MG132 proteasome inhibitor (5 µM) and subjected to time-lapse microscopy. 
The GFP fluorescence within the same field was recorded at the indicated 
time-points (top). U-2-OS cells were treated as above and immunostained with 
an FK2 antibody to conjugated ubiquitin (middle). U-2-OS cells stably 
expressing NBS1-RFP and GFP-53BP1 respectively, were co-cultivated in the 
same imaging chamber, microirradiated, and incubated for 30 min to allow 
assembly of both proteins at the DSB-flanking chromatin. Afterwards, MG132 
was added to the culture medium, the cells were subjected to live cell time-
lapse microscopy, and images were captured at indicated time-points (bottom). 
Note that the dissociation kinectics of 53BP1 (but not NBS1) after MG132 
addition coincides with the depletion of nuclear ubiquitin. Scale bars, 10 µm. 
(B) U-2-OS cells were treated with MG132 as in (A). At the indicated time-points, 
the cell lysates were acid extracted to enrich for nucleosomal histones as 
described 
(http://www.abcam.com/assets/pdf/protocols/Histone%20extraction%20protoc
ol.pdf) and analysed by immunoblotting with the indicated antibodies (left). 
Rabbit polyclonal antibodies used in this experiment include: H2A (Abcam; 
ab18255), H2B (Abcam; ab1790), H2AX (Cell Signalling, 2595), and H2AZ 
(Upstate, 07-594).  
 
 
  
 
 
  
 
 
Figure S7. Effects of RNF8 knockdown on DSB resection, nuclear mobility of 
53BP1, cell cycle progression, and DNA damage signalling 
(A) U-2-OS cells were transfected, or not with GFP-RNF8. Twenty-four h later, 
cells were co-transfected with indicated siRNAs for an additional 48 h, and the 
efficiency of the siRNAs was monitored by immunoblotting with anti-GFP 
antibody. MCM6 served as a loading control (left). U-2-OS cells were 
transfected with the indicated siRNAs for 48 h. Levels of the endogenous 
RNF8 protein were determined by immunoprecipitation of RNF8 with goat 
anti-RNF8 antibody (Ab-15850, AbCam), followed by immunoblotting with 
rabbit anti-RNF8 antibody (Ab-4183, AbCam) (right).  
(B) U-2-OS cells were treated with RNF8-targeting siRNA oligonucleotides for 48 
h, subjected to laser microirradiation, and 30 min later immunostained with 
the indicated antibodies. Accumulation of RPA in characteristic sub-chromatin 
‘microfoci’ within the microirradiated tracks (inset) indicates that the DSB 
resection and generation of single stranded DNA was not impaired by RNF8 
depletion. Mouse monoclonal antibody to the p34 subunit of RPA (Ab-1) was 
obtained from Lab Vision. Scale bars, 10 µm. 
 (C) U-2-OS cells conditionally expressing RNF8-targetting shRNA (U-2-
OS/shRNF8) were induced by Doxycycline (Dox). At the indicated time 
points, the cell cycle distribution was analyzed by flow cytometry as described 
(Mailand et al., 2006). 
(D) Two different clones (cl. 2 and cl. 3) of U-2-OS/shRNF8 cells were induced, 
or not by Dox, and subjected (or not) to IR (3 Gy). One hour later, the cell 
lysates were analysed by immunoblotting with antibodies to total or 
phosphorylated forms of the indicated proteins. Antibodies in this experiment 
include: SMC1 (rabbit; Abcam), SMC1-pS966 (rabbit; Abcam), p53 (mouse; 
DO-1), p53-pS15 (rabbit; Cell Signaling), Chk1 (mouse; DCS-316), Chk1-
pS317 (rabbit;  Cell Signaling), Chk2 (mouse; DCS-270 ), Chk2-pT68 (rabbit; 
Cell Signaling). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Figure S8. Effect of BRCA1 knockdown on accumulation of conjugated 
ubiquitin in the microlaser-generated DSB tracks 
(A) U-2-OS cells were treated with the indicated siRNA oligonucleotides for 72h, 
exposed to laser microirraditation, and after additional hour co-immunostained 
with antibodies to γ-H2AX and conjugated ubiquitin (FK2). The conditions in 
this experiment were identical to those applied in Figures 4B. The siRNA 
sequences for BRCA1 were as in Fig. S5. 
(B) U-2-OS cells were treated with siRNA oligonucleotides as in (A) and co-
immunostained with antibodies to BRCA1 and γ-H2AX. Note that the siRNA-
mediated downregulation of BRCA1 was very efficient (under these 
conditions, both the nucleoplasmic and the DSB-associated fluorescent signal 
of BRCA1 was reduced below the detection level). Scale bars, 10 µm. 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
  
 
 
Figure S9. Enhanced interaction of the catalytically inactive RNF8 with 
chromatin, and the MDC1 requirement for the IR-induced H2A ubiquitylation  
(A) U-2-OS cells were transfected with indicated FLAG-RNF8 constructs for 24 
h. Subsequently, cells were fractionated to separate soluble and chromatin-
enriched proteins as described (Mailand et al., 2006), and the resulting extracts 
were analyzed by immunoblotting. 
(B) U-2-OS cells or their derivatives stable expressing the MDC1-targetting 
shRNA (U-2-OS/shMDC1) were transfected with the indicated constructs and 
the H2A ubiquitylation was monitored as in Fig. 6C. 
(C) In vitro ubiquitylation of histones H2A, H2AX, H2B, and H3 by RNF8 was 
analyzed as in Fig. 6D. The degree of histone ubiquitylation was monitored by 
immunoblotting with anti-HA antibody on the same gel to directly compare 
the ability of RNF8 to ubiquitylate individual histones (upper panel). The blot 
was then stripped and reprobed with antibodies to individual histones (lower 
panels). 
(D) In vivo ubiquitylation of H2AX. U-2-OS/shRNF8 cells were left untreated or 
induced by addition of Dox. Twenty-four h later, cells were transfected with 
the indicated constructs, and the ubiquitylation of H2AX was monitored as in 
Fig. 6C. 
 (E) HEK293T cells were mock-treated or exposed to IR (20 Gy) for 1 h. Cells 
were then lysed in EBC buffer containing 500 mM NaCl and sonicated, and 
extracts were subjected to immunoprecipitation with anti-ubiquityl-H2A 
antibody (uH2A). Bound complexes were resolved by SDS-PAGE and 
analyzed by immunoblotting with Histone H2A antibody. IgH, 
immunoglobulin heavy chains. 
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Faustrup et al., http://www.jcb.org/cgi/content/full/jcb.200807137/DC1
Figure S1. Effects of USP7, Claspin, and Chk1 siRNAs. (A 
and B) siRNA-mediated depletion of USP7 down-regulates Claspin 
levels. U2OS cells were transfected with control or USP7 siRNAs 
for 72 h, and total cell extracts were processed for IB of indicated 
proteins (A) or for flow cytometric analysis of cell cycle distribution 
(B). (C) Claspin and Chk1 promote the stability of each other. 
U2OS cells were transfected with indicated siRNAs for 72 h, and 
the expression levels of Chk1 and Claspin were monitored by IB. 
SMC1 served as a loading control. siRNA sequences used were: 
USP7 No. 1 (59-GGCAACCUUUCAGUUCACUTT-39), USP7 No. 3 
(59-GGCGAAGUUUUAAAUGUAUTT-39), and control (Hsp70, 
59-GGGAGGACAAGACGUUCUATT-39). The Chk1 siRNA has 
been described previously (Syljuasen, R.G., C.S. Sorensen, L.T. 
Hansen, K. Fugger, C. Lundin, F. Johansson, T. Helleday, M. Seh-
ested, J. Lukas, and J. Bartek. 2005. Mol. Cell. Biol. 
25:3553–3562).
JCB S2
Figure S2. Characterization of U2OS/Myc-USP7 cell lines. (A) Conditional U2OS/Myc-USP7 WT cells were left untreated or induced to express the 
transgene by addition of DOX for 24 h. The cells were then fixed and immunostained with Myc antibody. Bars, 10 µm. (B) U2OS/Myc-USP7 cell lines were 
induced with DOX for the indicated times, stained with propidium iodide, and subjected to flow cytometry analysis as described previously (Mailand, N., J. 
Falck, C. Lukas, R.G. Syljuasen, M. Welcker, J. Bartek, and J. Lukas. 2000. Science. 288:1425–1429). (C) Stabilization of Mdm2 in U2OS/Myc-USP7 cells 
is dependent on the catalytic activity of USP7 but independent of cell cycle stage. U2OS/Myc-USP7 cell lines were left untreated or induced to express the 
transgenes by the addition of DOX for 24 h. The cells were then fixed and immunostained with Mdm2 and Cyclin A antibodies. Bars, 10 µm.
S3
Figure S3. Representative DNA profiles of the HU release experiment in Fig. 4 B. U2OS/Myc-USP7 WT cells treated as in Fig. 4 B were 
processed for flow cytometric analysis of DNA content.
